description,treatment_protocol_ch1,treatment_protocol_ch2,extract_protocol_ch1,extract_protocol_ch2
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
,Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML),,"Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.",
5511133076_A,,,"Total RNA was isolated with Qiagen Lipit Tissue kit according to manufacturer's protocol. RNA concentration was measured with NanoDrop, and quality control was performed with Agilent Bioanalyzer.",
5511133076_C,,,"Total RNA was isolated with Qiagen Lipit Tissue kit according to manufacturer's protocol. RNA concentration was measured with NanoDrop, and quality control was performed with Agilent Bioanalyzer.",
5511133076_E,,,"Total RNA was isolated with Qiagen Lipit Tissue kit according to manufacturer's protocol. RNA concentration was measured with NanoDrop, and quality control was performed with Agilent Bioanalyzer.",
5511133084_A,,,"Total RNA was isolated with Qiagen Lipit Tissue kit according to manufacturer's protocol. RNA concentration was measured with NanoDrop, and quality control was performed with Agilent Bioanalyzer.",
5511133084_C,,,"Total RNA was isolated with Qiagen Lipit Tissue kit according to manufacturer's protocol. RNA concentration was measured with NanoDrop, and quality control was performed with Agilent Bioanalyzer.",
5511133084_E,,,"Total RNA was isolated with Qiagen Lipit Tissue kit according to manufacturer's protocol. RNA concentration was measured with NanoDrop, and quality control was performed with Agilent Bioanalyzer.",
5511133076_B,,,"Total RNA was isolated with Qiagen Lipit Tissue kit according to manufacturer's protocol. RNA concentration was measured with NanoDrop, and quality control was performed with Agilent Bioanalyzer.",
5511133076_D,,,"Total RNA was isolated with Qiagen Lipit Tissue kit according to manufacturer's protocol. RNA concentration was measured with NanoDrop, and quality control was performed with Agilent Bioanalyzer.",
5511133076_F,,,"Total RNA was isolated with Qiagen Lipit Tissue kit according to manufacturer's protocol. RNA concentration was measured with NanoDrop, and quality control was performed with Agilent Bioanalyzer.",
5511133084_B,,,"Total RNA was isolated with Qiagen Lipit Tissue kit according to manufacturer's protocol. RNA concentration was measured with NanoDrop, and quality control was performed with Agilent Bioanalyzer.",
5511133084_D,,,"Total RNA was isolated with Qiagen Lipit Tissue kit according to manufacturer's protocol. RNA concentration was measured with NanoDrop, and quality control was performed with Agilent Bioanalyzer.",
5511133084_F,,,"Total RNA was isolated with Qiagen Lipit Tissue kit according to manufacturer's protocol. RNA concentration was measured with NanoDrop, and quality control was performed with Agilent Bioanalyzer.",
,,,"Mammary tissues without lymph nodes from two mice of each genotype were collected, frozen in liquid nitrogen, and stored at -80 C. Total RNA was extracted using TRIzol reagent, followed by a cleanup step using the RNeasy Plus Mini Kit (QIAGEN). Poly(A) RNA was purified twice from 1 mg total RNA and cDNA was synthesized using SuperScript II (Invitrogen) and TruSeq RNA Sample Preparation Kit (Illumina Inc., San Diego, CA), and sequenced using HiSeq 2000 (Illumina).",
,,,"Mammary tissues without lymph nodes from two mice of each genotype were collected, frozen in liquid nitrogen, and stored at -80 C. Total RNA was extracted using TRIzol reagent, followed by a cleanup step using the RNeasy Plus Mini Kit (QIAGEN). Poly(A) RNA was purified twice from 1 mg total RNA and cDNA was synthesized using SuperScript II (Invitrogen) and TruSeq RNA Sample Preparation Kit (Illumina Inc., San Diego, CA), and sequenced using HiSeq 2000 (Illumina).",
,,,"Mammary tissues without lymph nodes from two mice of each genotype were collected, frozen in liquid nitrogen, and stored at -80 C. Total RNA was extracted using TRIzol reagent, followed by a cleanup step using the RNeasy Plus Mini Kit (QIAGEN). Poly(A) RNA was purified twice from 1 mg total RNA and cDNA was synthesized using SuperScript II (Invitrogen) and TruSeq RNA Sample Preparation Kit (Illumina Inc., San Diego, CA), and sequenced using HiSeq 2000 (Illumina).",
,,,"Mammary tissues without lymph nodes from two mice of each genotype were collected, frozen in liquid nitrogen, and stored at -80 C. Total RNA was extracted using TRIzol reagent, followed by a cleanup step using the RNeasy Plus Mini Kit (QIAGEN). Poly(A) RNA was purified twice from 1 mg total RNA and cDNA was synthesized using SuperScript II (Invitrogen) and TruSeq RNA Sample Preparation Kit (Illumina Inc., San Diego, CA), and sequenced using HiSeq 2000 (Illumina).",
,,,"Mammary tissues without lymph nodes from two mice of each genotype were collected, frozen in liquid nitrogen, and stored at -80 C. Total RNA was extracted using TRIzol reagent, followed by a cleanup step using the RNeasy Plus Mini Kit (QIAGEN). Poly(A) RNA was purified twice from 1 mg total RNA and cDNA was synthesized using SuperScript II (Invitrogen) and TruSeq RNA Sample Preparation Kit (Illumina Inc., San Diego, CA), and sequenced using HiSeq 2000 (Illumina).",
,,,"Mammary tissues without lymph nodes from two mice of each genotype were collected, frozen in liquid nitrogen, and stored at -80 C. Total RNA was extracted using TRIzol reagent, followed by a cleanup step using the RNeasy Plus Mini Kit (QIAGEN). Poly(A) RNA was purified twice from 1 mg total RNA and cDNA was synthesized using SuperScript II (Invitrogen) and TruSeq RNA Sample Preparation Kit (Illumina Inc., San Diego, CA), and sequenced using HiSeq 2000 (Illumina).",
,,,"Mammary tissues without lymph nodes from two mice of each genotype were collected, frozen in liquid nitrogen, and stored at -80 C. Total RNA was extracted using TRIzol reagent, followed by a cleanup step using the RNeasy Plus Mini Kit (QIAGEN). Poly(A) RNA was purified twice from 1 mg total RNA and cDNA was synthesized using SuperScript II (Invitrogen) and TruSeq RNA Sample Preparation Kit (Illumina Inc., San Diego, CA), and sequenced using HiSeq 2000 (Illumina).",
,,,"Mammary tissues without lymph nodes from two mice of each genotype were collected, frozen in liquid nitrogen, and stored at -80 C. Total RNA was extracted using TRIzol reagent, followed by a cleanup step using the RNeasy Plus Mini Kit (QIAGEN). Poly(A) RNA was purified twice from 1 mg total RNA and cDNA was synthesized using SuperScript II (Invitrogen) and TruSeq RNA Sample Preparation Kit (Illumina Inc., San Diego, CA), and sequenced using HiSeq 2000 (Illumina).",
,,,"Mammary tissues without lymph nodes from two mice of each genotype were collected, frozen in liquid nitrogen, and stored at -80 C. Total RNA was extracted using TRIzol reagent, followed by a cleanup step using the RNeasy Plus Mini Kit (QIAGEN). Poly(A) RNA was purified twice from 1 mg total RNA and cDNA was synthesized using SuperScript II (Invitrogen) and TruSeq RNA Sample Preparation Kit (Illumina Inc., San Diego, CA), and sequenced using HiSeq 2000 (Illumina).",
,,,"Mammary tissues without lymph nodes from two mice of each genotype were collected, frozen in liquid nitrogen, and stored at -80 C. Total RNA was extracted using TRIzol reagent, followed by a cleanup step using the RNeasy Plus Mini Kit (QIAGEN). Poly(A) RNA was purified twice from 1 mg total RNA and cDNA was synthesized using SuperScript II (Invitrogen) and TruSeq RNA Sample Preparation Kit (Illumina Inc., San Diego, CA), and sequenced using HiSeq 2000 (Illumina).",
,,,"Mammary tissues without lymph nodes from two mice of each genotype were collected, frozen in liquid nitrogen, and stored at -80 C. Total RNA was extracted using TRIzol reagent, followed by a cleanup step using the RNeasy Plus Mini Kit (QIAGEN). Poly(A) RNA was purified twice from 1 mg total RNA and cDNA was synthesized using SuperScript II (Invitrogen) and TruSeq RNA Sample Preparation Kit (Illumina Inc., San Diego, CA), and sequenced using HiSeq 2000 (Illumina).",
,,,"Mammary tissues without lymph nodes from two mice of each genotype were collected, frozen in liquid nitrogen, and stored at -80 C. Total RNA was extracted using TRIzol reagent, followed by a cleanup step using the RNeasy Plus Mini Kit (QIAGEN). Poly(A) RNA was purified twice from 1 mg total RNA and cDNA was synthesized using SuperScript II (Invitrogen) and TruSeq RNA Sample Preparation Kit (Illumina Inc., San Diego, CA), and sequenced using HiSeq 2000 (Illumina).",
,,,"Mammary tissues without lymph nodes from two mice of each genotype were collected, frozen in liquid nitrogen, and stored at -80 C. Total RNA was extracted using TRIzol reagent, followed by a cleanup step using the RNeasy Plus Mini Kit (QIAGEN). Poly(A) RNA was purified twice from 1 mg total RNA and cDNA was synthesized using SuperScript II (Invitrogen) and TruSeq RNA Sample Preparation Kit (Illumina Inc., San Diego, CA), and sequenced using HiSeq 2000 (Illumina).",
,,,"Mammary tissues without lymph nodes from two mice of each genotype were collected, frozen in liquid nitrogen, and stored at -80 C. Total RNA was extracted using TRIzol reagent, followed by a cleanup step using the RNeasy Plus Mini Kit (QIAGEN). Poly(A) RNA was purified twice from 1 mg total RNA and cDNA was synthesized using SuperScript II (Invitrogen) and TruSeq RNA Sample Preparation Kit (Illumina Inc., San Diego, CA), and sequenced using HiSeq 2000 (Illumina).",
,,,"Mammary tissues without lymph nodes from two mice of each genotype were collected, frozen in liquid nitrogen, and stored at -80 C. Total RNA was extracted using TRIzol reagent, followed by a cleanup step using the RNeasy Plus Mini Kit (QIAGEN). Poly(A) RNA was purified twice from 1 mg total RNA and cDNA was synthesized using SuperScript II (Invitrogen) and TruSeq RNA Sample Preparation Kit (Illumina Inc., San Diego, CA), and sequenced using HiSeq 2000 (Illumina).",
,,,"Mammary tissues without lymph nodes from two mice of each genotype were collected, frozen in liquid nitrogen, and stored at -80 C. Total RNA was extracted using TRIzol reagent, followed by a cleanup step using the RNeasy Plus Mini Kit (QIAGEN). Poly(A) RNA was purified twice from 1 mg total RNA and cDNA was synthesized using SuperScript II (Invitrogen) and TruSeq RNA Sample Preparation Kit (Illumina Inc., San Diego, CA), and sequenced using HiSeq 2000 (Illumina).",
,,,"Mammary tissues without lymph nodes from two mice of each genotype were collected, frozen in liquid nitrogen, and stored at -80 C. Total RNA was extracted using TRIzol reagent, followed by a cleanup step using the RNeasy Plus Mini Kit (QIAGEN). Poly(A) RNA was purified twice from 1 mg total RNA and cDNA was synthesized using SuperScript II (Invitrogen) and TruSeq RNA Sample Preparation Kit (Illumina Inc., San Diego, CA), and sequenced using HiSeq 2000 (Illumina).",
,,,"Mammary tissues without lymph nodes from two mice of each genotype were collected, frozen in liquid nitrogen, and stored at -80 C. Total RNA was extracted using TRIzol reagent, followed by a cleanup step using the RNeasy Plus Mini Kit (QIAGEN). Poly(A) RNA was purified twice from 1 mg total RNA and cDNA was synthesized using SuperScript II (Invitrogen) and TruSeq RNA Sample Preparation Kit (Illumina Inc., San Diego, CA), and sequenced using HiSeq 2000 (Illumina).",
,,,"Mammary tissues without lymph nodes from two mice of each genotype were collected, frozen in liquid nitrogen, and stored at -80 C. Total RNA was extracted using TRIzol reagent, followed by a cleanup step using the RNeasy Plus Mini Kit (QIAGEN). Poly(A) RNA was purified twice from 1 mg total RNA and cDNA was synthesized using SuperScript II (Invitrogen) and TruSeq RNA Sample Preparation Kit (Illumina Inc., San Diego, CA), and sequenced using HiSeq 2000 (Illumina).",
,,,"Mammary tissues without lymph nodes from two mice of each genotype were collected, frozen in liquid nitrogen, and stored at -80 C. Total RNA was extracted using TRIzol reagent, followed by a cleanup step using the RNeasy Plus Mini Kit (QIAGEN). Poly(A) RNA was purified twice from 1 mg total RNA and cDNA was synthesized using SuperScript II (Invitrogen) and TruSeq RNA Sample Preparation Kit (Illumina Inc., San Diego, CA), and sequenced using HiSeq 2000 (Illumina).",
,,,"Mammary tissues without lymph nodes from two mice of each genotype were collected, frozen in liquid nitrogen, and stored at -80 C. Total RNA was extracted using TRIzol reagent, followed by a cleanup step using the RNeasy Plus Mini Kit (QIAGEN). Poly(A) RNA was purified twice from 1 mg total RNA and cDNA was synthesized using SuperScript II (Invitrogen) and TruSeq RNA Sample Preparation Kit (Illumina Inc., San Diego, CA), and sequenced using HiSeq 2000 (Illumina).",
,,,"Mammary tissues without lymph nodes from two mice of each genotype were collected, frozen in liquid nitrogen, and stored at -80 C. Total RNA was extracted using TRIzol reagent, followed by a cleanup step using the RNeasy Plus Mini Kit (QIAGEN). Poly(A) RNA was purified twice from 1 mg total RNA and cDNA was synthesized using SuperScript II (Invitrogen) and TruSeq RNA Sample Preparation Kit (Illumina Inc., San Diego, CA), and sequenced using HiSeq 2000 (Illumina).",
,,,"Mammary tissues without lymph nodes from two mice of each genotype were collected, frozen in liquid nitrogen, and stored at -80 C. Total RNA was extracted using TRIzol reagent, followed by a cleanup step using the RNeasy Plus Mini Kit (QIAGEN). Poly(A) RNA was purified twice from 1 mg total RNA and cDNA was synthesized using SuperScript II (Invitrogen) and TruSeq RNA Sample Preparation Kit (Illumina Inc., San Diego, CA), and sequenced using HiSeq 2000 (Illumina).",
,,,"Mammary tissues without lymph nodes from two mice of each genotype were collected, frozen in liquid nitrogen, and stored at -80 C. Total RNA was extracted using TRIzol reagent, followed by a cleanup step using the RNeasy Plus Mini Kit (QIAGEN). Poly(A) RNA was purified twice from 1 mg total RNA and cDNA was synthesized using SuperScript II (Invitrogen) and TruSeq RNA Sample Preparation Kit (Illumina Inc., San Diego, CA), and sequenced using HiSeq 2000 (Illumina).",
,,,"Mammary tissues without lymph nodes from two mice of each genotype were collected, frozen in liquid nitrogen, and stored at -80 C. Total RNA was extracted using TRIzol reagent, followed by a cleanup step using the RNeasy Plus Mini Kit (QIAGEN). Poly(A) RNA was purified twice from 1 mg total RNA and cDNA was synthesized using SuperScript II (Invitrogen) and TruSeq RNA Sample Preparation Kit (Illumina Inc., San Diego, CA), and sequenced using HiSeq 2000 (Illumina).",
,,,"Mammary tissues without lymph nodes from two mice of each genotype were collected, frozen in liquid nitrogen, and stored at -80 C. Total RNA was extracted using TRIzol reagent, followed by a cleanup step using the RNeasy Plus Mini Kit (QIAGEN). Poly(A) RNA was purified twice from 1 mg total RNA and cDNA was synthesized using SuperScript II (Invitrogen) and TruSeq RNA Sample Preparation Kit (Illumina Inc., San Diego, CA), and sequenced using HiSeq 2000 (Illumina).",
,,,"Mammary tissues without lymph nodes from two mice of each genotype were collected, frozen in liquid nitrogen, and stored at -80 C. Total RNA was extracted using TRIzol reagent, followed by a cleanup step using the RNeasy Plus Mini Kit (QIAGEN). Poly(A) RNA was purified twice from 1 mg total RNA and cDNA was synthesized using SuperScript II (Invitrogen) and TruSeq RNA Sample Preparation Kit (Illumina Inc., San Diego, CA), and sequenced using HiSeq 2000 (Illumina).",
,,,"Mammary tissues without lymph nodes from two mice of each genotype were collected, frozen in liquid nitrogen, and stored at -80 C. Total RNA was extracted using TRIzol reagent, followed by a cleanup step using the RNeasy Plus Mini Kit (QIAGEN). Poly(A) RNA was purified twice from 1 mg total RNA and cDNA was synthesized using SuperScript II (Invitrogen) and TruSeq RNA Sample Preparation Kit (Illumina Inc., San Diego, CA), and sequenced using HiSeq 2000 (Illumina).",
,,,"Mammary tissues without lymph nodes from two mice of each genotype were collected, frozen in liquid nitrogen, and stored at -80 C. Total RNA was extracted using TRIzol reagent, followed by a cleanup step using the RNeasy Plus Mini Kit (QIAGEN). Poly(A) RNA was purified twice from 1 mg total RNA and cDNA was synthesized using SuperScript II (Invitrogen) and TruSeq RNA Sample Preparation Kit (Illumina Inc., San Diego, CA), and sequenced using HiSeq 2000 (Illumina).",
,,,"Mammary tissues without lymph nodes from two mice of each genotype were collected, frozen in liquid nitrogen, and stored at -80 C. Total RNA was extracted using TRIzol reagent, followed by a cleanup step using the RNeasy Plus Mini Kit (QIAGEN). Poly(A) RNA was purified twice from 1 mg total RNA and cDNA was synthesized using SuperScript II (Invitrogen) and TruSeq RNA Sample Preparation Kit (Illumina Inc., San Diego, CA), and sequenced using HiSeq 2000 (Illumina).",
,,,"Mammary tissues without lymph nodes from two mice of each genotype were collected, frozen in liquid nitrogen, and stored at -80 C. Total RNA was extracted using TRIzol reagent, followed by a cleanup step using the RNeasy Plus Mini Kit (QIAGEN). Poly(A) RNA was purified twice from 1 mg total RNA and cDNA was synthesized using SuperScript II (Invitrogen) and TruSeq RNA Sample Preparation Kit (Illumina Inc., San Diego, CA), and sequenced using HiSeq 2000 (Illumina).",
,,,Total RNA was extracted using Qiagen RNA Mini kits according to the manufacturer's instructions.,
,,,Total RNA was extracted using Qiagen RNA Mini kits according to the manufacturer's instructions.,
,,,Total RNA was extracted using Qiagen RNA Mini kits according to the manufacturer's instructions.,
,,,Total RNA was extracted using Qiagen RNA Mini kits according to the manufacturer's instructions.,
,,,Total RNA was extracted using Qiagen RNA Mini kits according to the manufacturer's instructions.,
,,,Total RNA was extracted using Qiagen RNA Mini kits according to the manufacturer's instructions.,
,,,Total RNA was extracted using Qiagen RNA Mini kits according to the manufacturer's instructions.,
,,,Total RNA was extracted using Qiagen RNA Mini kits according to the manufacturer's instructions.,
,,,Total RNA was extracted using Qiagen RNA Mini kits according to the manufacturer's instructions.,
,,,Total RNA was extracted using Qiagen RNA Mini kits according to the manufacturer's instructions.,
,,,Total RNA was extracted using Qiagen RNA Mini kits according to the manufacturer's instructions.,
,,,Total RNA was extracted using Qiagen RNA Mini kits according to the manufacturer's instructions.,
n/a,n/a,,"Total RNA was isolated from samples using Plant RNA Reagent (Invitrogen, California, USA), according to the manufacturers instruction. RNA was further purified through a Qiagen RNeasy column (Qiagen, Australia) after pre-treatment with RNase-free DNase I",
n/a,n/a,,"Total RNA was isolated from samples using Plant RNA Reagent (Invitrogen, California, USA), according to the manufacturers instruction. RNA was further purified through a Qiagen RNeasy column (Qiagen, Australia) after pre-treatment with RNase-free DNase I",
n/a,n/a,,"Total RNA was isolated from samples using Plant RNA Reagent (Invitrogen, California, USA), according to the manufacturers instruction. RNA was further purified through a Qiagen RNeasy column (Qiagen, Australia) after pre-treatment with RNase-free DNase I",
n/a,n/a,,"Total RNA was isolated from samples using Plant RNA Reagent (Invitrogen, California, USA), according to the manufacturers instruction. RNA was further purified through a Qiagen RNeasy column (Qiagen, Australia) after pre-treatment with RNase-free DNase I",
n/a,n/a,,"Total RNA was isolated from samples using Plant RNA Reagent (Invitrogen, California, USA), according to the manufacturers instruction. RNA was further purified through a Qiagen RNeasy column (Qiagen, Australia) after pre-treatment with RNase-free DNase I",
n/a,n/a,,"Total RNA was isolated from samples using Plant RNA Reagent (Invitrogen, California, USA), according to the manufacturers instruction. RNA was further purified through a Qiagen RNeasy column (Qiagen, Australia) after pre-treatment with RNase-free DNase I",
n/a,n/a,,"Total RNA was isolated from samples using Plant RNA Reagent (Invitrogen, California, USA), according to the manufacturers instruction. RNA was further purified through a Qiagen RNeasy column (Qiagen, Australia) after pre-treatment with RNase-free DNase I",
n/a,n/a,,"Total RNA was isolated from samples using Plant RNA Reagent (Invitrogen, California, USA), according to the manufacturers instruction. RNA was further purified through a Qiagen RNeasy column (Qiagen, Australia) after pre-treatment with RNase-free DNase I",
n/a,n/a,,"Total RNA was isolated from samples using Plant RNA Reagent (Invitrogen, California, USA), according to the manufacturers instruction. RNA was further purified through a Qiagen RNeasy column (Qiagen, Australia) after pre-treatment with RNase-free DNase I",
n/a,n/a,,"Total RNA was isolated from samples using Plant RNA Reagent (Invitrogen, California, USA), according to the manufacturers instruction. RNA was further purified through a Qiagen RNeasy column (Qiagen, Australia) after pre-treatment with RNase-free DNase I",
n/a,n/a,,"Total RNA was isolated from samples using Plant RNA Reagent (Invitrogen, California, USA), according to the manufacturers instruction. RNA was further purified through a Qiagen RNeasy column (Qiagen, Australia) after pre-treatment with RNase-free DNase I",
n/a,n/a,,"Total RNA was isolated from samples using Plant RNA Reagent (Invitrogen, California, USA), according to the manufacturers instruction. RNA was further purified through a Qiagen RNeasy column (Qiagen, Australia) after pre-treatment with RNase-free DNase I",
n/a,n/a,,"Total RNA was isolated from samples using Plant RNA Reagent (Invitrogen, California, USA), according to the manufacturers instruction. RNA was further purified through a Qiagen RNeasy column (Qiagen, Australia) after pre-treatment with RNase-free DNase I",
n/a,n/a,,"Total RNA was isolated from samples using Plant RNA Reagent (Invitrogen, California, USA), according to the manufacturers instruction. RNA was further purified through a Qiagen RNeasy column (Qiagen, Australia) after pre-treatment with RNase-free DNase I",
"Fertile_hpv6w_SP1_42 years;	This placental sample is of first  trimester normal pregnancy, underwent elective surgical termination. It is the first of eight, 6 weeks biological replicates sample, each from different individual woman.",,,"Placental samples were collected in sterile ice-cold phosphate buffered saline (PBS, pH 7.4). The tissue samples were quickly washed in ice-cold PBS to remove blood and debris, and separated from surrounding membranes, and villous portions were dissected from decidual and embryonic tissue under a dissecting microscope and further washed with sterile, cold PBS. The total RNA was extracted using Trizol (Agilent Technologies Singapore Pvt. Ltd., Shung Avenue, Singapore) and cleaned up with DNase I (Sigma Chemical Co., St. Louis, Missouri, USA) and subjected to re-extraction when it was necessary. The yield and purity of the extracted RNA was checked using standard spectrophotometric method and 1% agarose gel electrophoresis. Furthermore, RIN score of individual sample was determined using Bioanalyzer, RNA Chip kit and Software from Agilent Technologies (Santa Clara, CA, USA).",
"Fertile_hpv6w_SP4_26 years;	This placental sample is of first  trimester normal pregnancy, underwent elective surgical termination. It is the second of eight, 6 weeks biological replicates sample, each from different individual woman.",,,"Placental samples were collected in sterile ice-cold phosphate buffered saline (PBS, pH 7.4). The tissue samples were quickly washed in ice-cold PBS to remove blood and debris, and separated from surrounding membranes, and villous portions were dissected from decidual and embryonic tissue under a dissecting microscope and further washed with sterile, cold PBS. The total RNA was extracted using Trizol (Agilent Technologies Singapore Pvt. Ltd., Shung Avenue, Singapore) and cleaned up with DNase I (Sigma Chemical Co., St. Louis, Missouri, USA) and subjected to re-extraction when it was necessary. The yield and purity of the extracted RNA was checked using standard spectrophotometric method and 1% agarose gel electrophoresis. Furthermore, RIN score of individual sample was determined using Bioanalyzer, RNA Chip kit and Software from Agilent Technologies (Santa Clara, CA, USA).",
"Fertile_hpv6w_SP4.4_25 years;	This placental sample is of first  trimester normal pregnancy, underwent elective surgical termination. It is the third of eight, 6 weeks biological replicates sample, each from different individual woman.",,,"Placental samples were collected in sterile ice-cold phosphate buffered saline (PBS, pH 7.4). The tissue samples were quickly washed in ice-cold PBS to remove blood and debris, and separated from surrounding membranes, and villous portions were dissected from decidual and embryonic tissue under a dissecting microscope and further washed with sterile, cold PBS. The total RNA was extracted using Trizol (Agilent Technologies Singapore Pvt. Ltd., Shung Avenue, Singapore) and cleaned up with DNase I (Sigma Chemical Co., St. Louis, Missouri, USA) and subjected to re-extraction when it was necessary. The yield and purity of the extracted RNA was checked using standard spectrophotometric method and 1% agarose gel electrophoresis. Furthermore, RIN score of individual sample was determined using Bioanalyzer, RNA Chip kit and Software from Agilent Technologies (Santa Clara, CA, USA).",
"Fertile_hpv6w_SP17_27 years;	This placental sample is of first  trimester normal pregnancy, underwent elective surgical termination. It is the fourth of eight, 6 weeks biological replicates sample, each from different individual woman.",,,"Placental samples were collected in sterile ice-cold phosphate buffered saline (PBS, pH 7.4). The tissue samples were quickly washed in ice-cold PBS to remove blood and debris, and separated from surrounding membranes, and villous portions were dissected from decidual and embryonic tissue under a dissecting microscope and further washed with sterile, cold PBS. The total RNA was extracted using Trizol (Agilent Technologies Singapore Pvt. Ltd., Shung Avenue, Singapore) and cleaned up with DNase I (Sigma Chemical Co., St. Louis, Missouri, USA) and subjected to re-extraction when it was necessary. The yield and purity of the extracted RNA was checked using standard spectrophotometric method and 1% agarose gel electrophoresis. Furthermore, RIN score of individual sample was determined using Bioanalyzer, RNA Chip kit and Software from Agilent Technologies (Santa Clara, CA, USA).",
"Fertile_hpv6w_SP21_26 years;	This placental sample is of first  trimester normal pregnancy, underwent elective surgical termination. It is the fifth of eight, 6 weeks biological replicates sample, each from different individual woman.",,,"Placental samples were collected in sterile ice-cold phosphate buffered saline (PBS, pH 7.4). The tissue samples were quickly washed in ice-cold PBS to remove blood and debris, and separated from surrounding membranes, and villous portions were dissected from decidual and embryonic tissue under a dissecting microscope and further washed with sterile, cold PBS. The total RNA was extracted using Trizol (Agilent Technologies Singapore Pvt. Ltd., Shung Avenue, Singapore) and cleaned up with DNase I (Sigma Chemical Co., St. Louis, Missouri, USA) and subjected to re-extraction when it was necessary. The yield and purity of the extracted RNA was checked using standard spectrophotometric method and 1% agarose gel electrophoresis. Furthermore, RIN score of individual sample was determined using Bioanalyzer, RNA Chip kit and Software from Agilent Technologies (Santa Clara, CA, USA).",
"Fertile_hpv6w_SP26_30 years;	This placental sample is of first  trimester normal pregnancy, underwent elective surgical termination. It is the sixth of eight, 6 weeks biological replicates sample, each from different individual woman.",,,"Placental samples were collected in sterile ice-cold phosphate buffered saline (PBS, pH 7.4). The tissue samples were quickly washed in ice-cold PBS to remove blood and debris, and separated from surrounding membranes, and villous portions were dissected from decidual and embryonic tissue under a dissecting microscope and further washed with sterile, cold PBS. The total RNA was extracted using Trizol (Agilent Technologies Singapore Pvt. Ltd., Shung Avenue, Singapore) and cleaned up with DNase I (Sigma Chemical Co., St. Louis, Missouri, USA) and subjected to re-extraction when it was necessary. The yield and purity of the extracted RNA was checked using standard spectrophotometric method and 1% agarose gel electrophoresis. Furthermore, RIN score of individual sample was determined using Bioanalyzer, RNA Chip kit and Software from Agilent Technologies (Santa Clara, CA, USA).",
"Fertile_hpv6w_SP13_21 years;	This placental sample is of first  trimester normal pregnancy, underwent elective surgical termination. It is the seventh of eight, 6 weeks biological replicates sample, each from different individual woman.",,,"Placental samples were collected in sterile ice-cold phosphate buffered saline (PBS, pH 7.4). The tissue samples were quickly washed in ice-cold PBS to remove blood and debris, and separated from surrounding membranes, and villous portions were dissected from decidual and embryonic tissue under a dissecting microscope and further washed with sterile, cold PBS. The total RNA was extracted using Trizol (Agilent Technologies Singapore Pvt. Ltd., Shung Avenue, Singapore) and cleaned up with DNase I (Sigma Chemical Co., St. Louis, Missouri, USA) and subjected to re-extraction when it was necessary. The yield and purity of the extracted RNA was checked using standard spectrophotometric method and 1% agarose gel electrophoresis. Furthermore, RIN score of individual sample was determined using Bioanalyzer, RNA Chip kit and Software from Agilent Technologies (Santa Clara, CA, USA).",
"Fertile_hpv6w_SP23_26 years;	This placental sample is of first  trimester normal pregnancy, underwent elective surgical termination. It is the eighth of eight, 6 weeks biological replicates sample, each from different individual woman.",,,"Placental samples were collected in sterile ice-cold phosphate buffered saline (PBS, pH 7.4). The tissue samples were quickly washed in ice-cold PBS to remove blood and debris, and separated from surrounding membranes, and villous portions were dissected from decidual and embryonic tissue under a dissecting microscope and further washed with sterile, cold PBS. The total RNA was extracted using Trizol (Agilent Technologies Singapore Pvt. Ltd., Shung Avenue, Singapore) and cleaned up with DNase I (Sigma Chemical Co., St. Louis, Missouri, USA) and subjected to re-extraction when it was necessary. The yield and purity of the extracted RNA was checked using standard spectrophotometric method and 1% agarose gel electrophoresis. Furthermore, RIN score of individual sample was determined using Bioanalyzer, RNA Chip kit and Software from Agilent Technologies (Santa Clara, CA, USA).",
"Fertile_hpv7w_SP2_26 years;	This placental sample is of first  trimester normal pregnancy, underwent elective surgical termination. It is the first of nine, 7 weeks biological replicates sample, each from different individual woman.",,,"Placental samples were collected in sterile ice-cold phosphate buffered saline (PBS, pH 7.4). The tissue samples were quickly washed in ice-cold PBS to remove blood and debris, and separated from surrounding membranes, and villous portions were dissected from decidual and embryonic tissue under a dissecting microscope and further washed with sterile, cold PBS. The total RNA was extracted using Trizol (Agilent Technologies Singapore Pvt. Ltd., Shung Avenue, Singapore) and cleaned up with DNase I (Sigma Chemical Co., St. Louis, Missouri, USA) and subjected to re-extraction when it was necessary. The yield and purity of the extracted RNA was checked using standard spectrophotometric method and 1% agarose gel electrophoresis. Furthermore, RIN score of individual sample was determined using Bioanalyzer, RNA Chip kit and Software from Agilent Technologies (Santa Clara, CA, USA).",
"Fertile_hpv7w_SP3.3_24 years;	This placental sample is of first  trimester normal pregnancy, underwent elective surgical termination. It is the second of nine, 7 weeks biological replicates sample, each from different individual woman.",,,"Placental samples were collected in sterile ice-cold phosphate buffered saline (PBS, pH 7.4). The tissue samples were quickly washed in ice-cold PBS to remove blood and debris, and separated from surrounding membranes, and villous portions were dissected from decidual and embryonic tissue under a dissecting microscope and further washed with sterile, cold PBS. The total RNA was extracted using Trizol (Agilent Technologies Singapore Pvt. Ltd., Shung Avenue, Singapore) and cleaned up with DNase I (Sigma Chemical Co., St. Louis, Missouri, USA) and subjected to re-extraction when it was necessary. The yield and purity of the extracted RNA was checked using standard spectrophotometric method and 1% agarose gel electrophoresis. Furthermore, RIN score of individual sample was determined using Bioanalyzer, RNA Chip kit and Software from Agilent Technologies (Santa Clara, CA, USA).",
"Fertile_hpv7w_SP5_26 years;	This placental sample is of first  trimester normal pregnancy, underwent elective surgical termination. It is the third of nine, 7 weeks biological replicates sample, each from different individual woman.",,,"Placental samples were collected in sterile ice-cold phosphate buffered saline (PBS, pH 7.4). The tissue samples were quickly washed in ice-cold PBS to remove blood and debris, and separated from surrounding membranes, and villous portions were dissected from decidual and embryonic tissue under a dissecting microscope and further washed with sterile, cold PBS. The total RNA was extracted using Trizol (Agilent Technologies Singapore Pvt. Ltd., Shung Avenue, Singapore) and cleaned up with DNase I (Sigma Chemical Co., St. Louis, Missouri, USA) and subjected to re-extraction when it was necessary. The yield and purity of the extracted RNA was checked using standard spectrophotometric method and 1% agarose gel electrophoresis. Furthermore, RIN score of individual sample was determined using Bioanalyzer, RNA Chip kit and Software from Agilent Technologies (Santa Clara, CA, USA).",
"Fertile_hpv7w_SP11_25 years;	This placental sample is of first  trimester normal pregnancy, underwent elective surgical termination. It is the fourth of nine, 7 weeks biological replicates sample, each from different individual woman.",,,"Placental samples were collected in sterile ice-cold phosphate buffered saline (PBS, pH 7.4). The tissue samples were quickly washed in ice-cold PBS to remove blood and debris, and separated from surrounding membranes, and villous portions were dissected from decidual and embryonic tissue under a dissecting microscope and further washed with sterile, cold PBS. The total RNA was extracted using Trizol (Agilent Technologies Singapore Pvt. Ltd., Shung Avenue, Singapore) and cleaned up with DNase I (Sigma Chemical Co., St. Louis, Missouri, USA) and subjected to re-extraction when it was necessary. The yield and purity of the extracted RNA was checked using standard spectrophotometric method and 1% agarose gel electrophoresis. Furthermore, RIN score of individual sample was determined using Bioanalyzer, RNA Chip kit and Software from Agilent Technologies (Santa Clara, CA, USA).",
"Fertile_hpv7w_SP25_26 years;	This placental sample is of first  trimester normal pregnancy, underwent elective surgical termination. It is the fifth of nine, 7 weeks biological replicates sample, each from different individual woman.",,,"Placental samples were collected in sterile ice-cold phosphate buffered saline (PBS, pH 7.4). The tissue samples were quickly washed in ice-cold PBS to remove blood and debris, and separated from surrounding membranes, and villous portions were dissected from decidual and embryonic tissue under a dissecting microscope and further washed with sterile, cold PBS. The total RNA was extracted using Trizol (Agilent Technologies Singapore Pvt. Ltd., Shung Avenue, Singapore) and cleaned up with DNase I (Sigma Chemical Co., St. Louis, Missouri, USA) and subjected to re-extraction when it was necessary. The yield and purity of the extracted RNA was checked using standard spectrophotometric method and 1% agarose gel electrophoresis. Furthermore, RIN score of individual sample was determined using Bioanalyzer, RNA Chip kit and Software from Agilent Technologies (Santa Clara, CA, USA).",
"Fertile_hpv7w_SP29_25 years;	This placental sample is of first  trimester normal pregnancy, underwent elective surgical termination. It is the sixth of nine, 7 weeks biological replicates sample, each from different individual woman.",,,"Placental samples were collected in sterile ice-cold phosphate buffered saline (PBS, pH 7.4). The tissue samples were quickly washed in ice-cold PBS to remove blood and debris, and separated from surrounding membranes, and villous portions were dissected from decidual and embryonic tissue under a dissecting microscope and further washed with sterile, cold PBS. The total RNA was extracted using Trizol (Agilent Technologies Singapore Pvt. Ltd., Shung Avenue, Singapore) and cleaned up with DNase I (Sigma Chemical Co., St. Louis, Missouri, USA) and subjected to re-extraction when it was necessary. The yield and purity of the extracted RNA was checked using standard spectrophotometric method and 1% agarose gel electrophoresis. Furthermore, RIN score of individual sample was determined using Bioanalyzer, RNA Chip kit and Software from Agilent Technologies (Santa Clara, CA, USA).",
"Fertile_hpv7w_SP2.2_25 years;	This placental sample is of first  trimester normal pregnancy, underwent elective surgical termination. It is the seventh of nine, 7 weeks biological replicates sample, each from different individual woman.",,,"Placental samples were collected in sterile ice-cold phosphate buffered saline (PBS, pH 7.4). The tissue samples were quickly washed in ice-cold PBS to remove blood and debris, and separated from surrounding membranes, and villous portions were dissected from decidual and embryonic tissue under a dissecting microscope and further washed with sterile, cold PBS. The total RNA was extracted using Trizol (Agilent Technologies Singapore Pvt. Ltd., Shung Avenue, Singapore) and cleaned up with DNase I (Sigma Chemical Co., St. Louis, Missouri, USA) and subjected to re-extraction when it was necessary. The yield and purity of the extracted RNA was checked using standard spectrophotometric method and 1% agarose gel electrophoresis. Furthermore, RIN score of individual sample was determined using Bioanalyzer, RNA Chip kit and Software from Agilent Technologies (Santa Clara, CA, USA).",
"Fertile_hpv7w_SP27_24 years;	This placental sample is of first  trimester normal pregnancy, underwent elective surgical termination. It is the eighth of nine, 7 weeks biological replicates sample, each from different individual woman.",,,"Placental samples were collected in sterile ice-cold phosphate buffered saline (PBS, pH 7.4). The tissue samples were quickly washed in ice-cold PBS to remove blood and debris, and separated from surrounding membranes, and villous portions were dissected from decidual and embryonic tissue under a dissecting microscope and further washed with sterile, cold PBS. The total RNA was extracted using Trizol (Agilent Technologies Singapore Pvt. Ltd., Shung Avenue, Singapore) and cleaned up with DNase I (Sigma Chemical Co., St. Louis, Missouri, USA) and subjected to re-extraction when it was necessary. The yield and purity of the extracted RNA was checked using standard spectrophotometric method and 1% agarose gel electrophoresis. Furthermore, RIN score of individual sample was determined using Bioanalyzer, RNA Chip kit and Software from Agilent Technologies (Santa Clara, CA, USA).",
"Fertile_hpv7w_SP30_22 years;	This placental sample is of first  trimester normal pregnancy, underwent elective surgical termination. It is the nineth of nine, 7 weeks biological replicates sample, each from different individual woman.",,,"Placental samples were collected in sterile ice-cold phosphate buffered saline (PBS, pH 7.4). The tissue samples were quickly washed in ice-cold PBS to remove blood and debris, and separated from surrounding membranes, and villous portions were dissected from decidual and embryonic tissue under a dissecting microscope and further washed with sterile, cold PBS. The total RNA was extracted using Trizol (Agilent Technologies Singapore Pvt. Ltd., Shung Avenue, Singapore) and cleaned up with DNase I (Sigma Chemical Co., St. Louis, Missouri, USA) and subjected to re-extraction when it was necessary. The yield and purity of the extracted RNA was checked using standard spectrophotometric method and 1% agarose gel electrophoresis. Furthermore, RIN score of individual sample was determined using Bioanalyzer, RNA Chip kit and Software from Agilent Technologies (Santa Clara, CA, USA).",
"Fertile_hpv8w_SP3_30 years;	This placental sample is of first  trimester normal pregnancy, underwent elective surgical termination. It is the first of eight, 8 weeks biological replicates sample, each from different individual woman.",,,"Placental samples were collected in sterile ice-cold phosphate buffered saline (PBS, pH 7.4). The tissue samples were quickly washed in ice-cold PBS to remove blood and debris, and separated from surrounding membranes, and villous portions were dissected from decidual and embryonic tissue under a dissecting microscope and further washed with sterile, cold PBS. The total RNA was extracted using Trizol (Agilent Technologies Singapore Pvt. Ltd., Shung Avenue, Singapore) and cleaned up with DNase I (Sigma Chemical Co., St. Louis, Missouri, USA) and subjected to re-extraction when it was necessary. The yield and purity of the extracted RNA was checked using standard spectrophotometric method and 1% agarose gel electrophoresis. Furthermore, RIN score of individual sample was determined using Bioanalyzer, RNA Chip kit and Software from Agilent Technologies (Santa Clara, CA, USA).",
"Fertile_hpv8w_SP8_26 years;	This placental sample is of first  trimester normal pregnancy, underwent elective surgical termination. It is the second of eight, 8 weeks biological replicates sample, each from different individual woman.",,,"Placental samples were collected in sterile ice-cold phosphate buffered saline (PBS, pH 7.4). The tissue samples were quickly washed in ice-cold PBS to remove blood and debris, and separated from surrounding membranes, and villous portions were dissected from decidual and embryonic tissue under a dissecting microscope and further washed with sterile, cold PBS. The total RNA was extracted using Trizol (Agilent Technologies Singapore Pvt. Ltd., Shung Avenue, Singapore) and cleaned up with DNase I (Sigma Chemical Co., St. Louis, Missouri, USA) and subjected to re-extraction when it was necessary. The yield and purity of the extracted RNA was checked using standard spectrophotometric method and 1% agarose gel electrophoresis. Furthermore, RIN score of individual sample was determined using Bioanalyzer, RNA Chip kit and Software from Agilent Technologies (Santa Clara, CA, USA).",
"Fertile_hpv8w_SP14_28 years;	This placental sample is of first  trimester normal pregnancy, underwent elective surgical termination. It is the third of eight, 8 weeks biological replicates sample, each from different individual woman.",,,"Placental samples were collected in sterile ice-cold phosphate buffered saline (PBS, pH 7.4). The tissue samples were quickly washed in ice-cold PBS to remove blood and debris, and separated from surrounding membranes, and villous portions were dissected from decidual and embryonic tissue under a dissecting microscope and further washed with sterile, cold PBS. The total RNA was extracted using Trizol (Agilent Technologies Singapore Pvt. Ltd., Shung Avenue, Singapore) and cleaned up with DNase I (Sigma Chemical Co., St. Louis, Missouri, USA) and subjected to re-extraction when it was necessary. The yield and purity of the extracted RNA was checked using standard spectrophotometric method and 1% agarose gel electrophoresis. Furthermore, RIN score of individual sample was determined using Bioanalyzer, RNA Chip kit and Software from Agilent Technologies (Santa Clara, CA, USA).",
"Fertile_hpv8w_SP22_23 years;	This placental sample is of first  trimester normal pregnancy, underwent elective surgical termination. It is the fourth of eight, 8 weeks biological replicates sample, each from different individual woman.",,,"Placental samples were collected in sterile ice-cold phosphate buffered saline (PBS, pH 7.4). The tissue samples were quickly washed in ice-cold PBS to remove blood and debris, and separated from surrounding membranes, and villous portions were dissected from decidual and embryonic tissue under a dissecting microscope and further washed with sterile, cold PBS. The total RNA was extracted using Trizol (Agilent Technologies Singapore Pvt. Ltd., Shung Avenue, Singapore) and cleaned up with DNase I (Sigma Chemical Co., St. Louis, Missouri, USA) and subjected to re-extraction when it was necessary. The yield and purity of the extracted RNA was checked using standard spectrophotometric method and 1% agarose gel electrophoresis. Furthermore, RIN score of individual sample was determined using Bioanalyzer, RNA Chip kit and Software from Agilent Technologies (Santa Clara, CA, USA).",
"Fertile_hpv8w_SP12_28 years;	This placental sample is of first  trimester normal pregnancy, underwent elective surgical termination. It is the fifth of eight, 8 weeks biological replicates sample, each from different individual woman.",,,"Placental samples were collected in sterile ice-cold phosphate buffered saline (PBS, pH 7.4). The tissue samples were quickly washed in ice-cold PBS to remove blood and debris, and separated from surrounding membranes, and villous portions were dissected from decidual and embryonic tissue under a dissecting microscope and further washed with sterile, cold PBS. The total RNA was extracted using Trizol (Agilent Technologies Singapore Pvt. Ltd., Shung Avenue, Singapore) and cleaned up with DNase I (Sigma Chemical Co., St. Louis, Missouri, USA) and subjected to re-extraction when it was necessary. The yield and purity of the extracted RNA was checked using standard spectrophotometric method and 1% agarose gel electrophoresis. Furthermore, RIN score of individual sample was determined using Bioanalyzer, RNA Chip kit and Software from Agilent Technologies (Santa Clara, CA, USA).",
"Fertile_hpv8w_SP5.5_26 years;	This placental sample is of first  trimester normal pregnancy, underwent elective surgical termination. It is the sixth of eight, 8 weeks biological replicates sample, each from different individual woman.",,,"Placental samples were collected in sterile ice-cold phosphate buffered saline (PBS, pH 7.4). The tissue samples were quickly washed in ice-cold PBS to remove blood and debris, and separated from surrounding membranes, and villous portions were dissected from decidual and embryonic tissue under a dissecting microscope and further washed with sterile, cold PBS. The total RNA was extracted using Trizol (Agilent Technologies Singapore Pvt. Ltd., Shung Avenue, Singapore) and cleaned up with DNase I (Sigma Chemical Co., St. Louis, Missouri, USA) and subjected to re-extraction when it was necessary. The yield and purity of the extracted RNA was checked using standard spectrophotometric method and 1% agarose gel electrophoresis. Furthermore, RIN score of individual sample was determined using Bioanalyzer, RNA Chip kit and Software from Agilent Technologies (Santa Clara, CA, USA).",
"Fertile_hpv8w_SP1.1_20 years;	This placental sample is of first  trimester normal pregnancy, underwent elective surgical termination. It is the seventh of eight, 8 weeks biological replicates sample, each from different individual woman.",,,"Placental samples were collected in sterile ice-cold phosphate buffered saline (PBS, pH 7.4). The tissue samples were quickly washed in ice-cold PBS to remove blood and debris, and separated from surrounding membranes, and villous portions were dissected from decidual and embryonic tissue under a dissecting microscope and further washed with sterile, cold PBS. The total RNA was extracted using Trizol (Agilent Technologies Singapore Pvt. Ltd., Shung Avenue, Singapore) and cleaned up with DNase I (Sigma Chemical Co., St. Louis, Missouri, USA) and subjected to re-extraction when it was necessary. The yield and purity of the extracted RNA was checked using standard spectrophotometric method and 1% agarose gel electrophoresis. Furthermore, RIN score of individual sample was determined using Bioanalyzer, RNA Chip kit and Software from Agilent Technologies (Santa Clara, CA, USA).",
"Fertile_hpv8w_SP7.7_20 years;	This placental sample is of first  trimester normal pregnancy, underwent elective surgical termination. It is the eighth of eight, 8 weeks biological replicates sample, each from different individual woman.",,,"Placental samples were collected in sterile ice-cold phosphate buffered saline (PBS, pH 7.4). The tissue samples were quickly washed in ice-cold PBS to remove blood and debris, and separated from surrounding membranes, and villous portions were dissected from decidual and embryonic tissue under a dissecting microscope and further washed with sterile, cold PBS. The total RNA was extracted using Trizol (Agilent Technologies Singapore Pvt. Ltd., Shung Avenue, Singapore) and cleaned up with DNase I (Sigma Chemical Co., St. Louis, Missouri, USA) and subjected to re-extraction when it was necessary. The yield and purity of the extracted RNA was checked using standard spectrophotometric method and 1% agarose gel electrophoresis. Furthermore, RIN score of individual sample was determined using Bioanalyzer, RNA Chip kit and Software from Agilent Technologies (Santa Clara, CA, USA).",
,,,"Genomic DNA was extracted from  peripheral blood using the Qiagen DNA Blood Mini Kit. DNA quality and quantity was assessed using a Nanodrop Spectrophotometer, PicoGreen and agarose gel electrophoresis.","Genomic DNA was extracted from  peripheral blood using the Qiagen DNA Blood Mini Kit. DNA quality and quantity was assessed using a Nanodrop Spectrophotometer, PicoGreen and agarose gel electrophoresis."
,Fresh lungs were harvested into RNA later (Ambion).,,Total RNA was isolated from lung homogenates by using TRIzol (Invitrogen). RNA quality was checked on Agilent Bioanalyzer.  All samples used for microarray analysis have high quality score (RIN >9).,
,Fresh lungs were harvested into RNA later (Ambion).,,Total RNA was isolated from lung homogenates by using TRIzol (Invitrogen). RNA quality was checked on Agilent Bioanalyzer.  All samples used for microarray analysis have high quality score (RIN >9).,
,Fresh lungs were harvested into RNA later (Ambion).,,Total RNA was isolated from lung homogenates by using TRIzol (Invitrogen). RNA quality was checked on Agilent Bioanalyzer.  All samples used for microarray analysis have high quality score (RIN >9).,
,,,"Genomic DNA was extracted from  peripheral blood using chemagen. DNA quality and quantity was assessed using a Nanodrop Spectrophotometer, PicoGreen and agarose gel electrophoresis.","Genomic DNA was extracted from  peripheral blood using chemagen. DNA quality and quantity was assessed using a Nanodrop Spectrophotometer, PicoGreen and agarose gel electrophoresis."
Gene expression data of Flk1 positive cells in Ebs differentiated for 3.5 days in a mesoderm inducing condition;	KB_D31off,0.5 microg/ml doxycycline from day 3.0 to day 3.5,,Trizol followed by extraction by 1-butanol and diethyl ether.,
Gene expression data of Flk1 positive cells in Ebs differentiated for 3.5 days in a mesoderm inducing condition. Etv2 was induced to overexpress from day 3.0 to 3.5 (0.5 microg/ml doxycycline).;	KB_D31on,0.5 microg/ml doxycycline from day 3.0 to day 3.5,,Trizol followed by extraction by 1-butanol and diethyl ether.,
Gene expression data of Flk1 positive cells in Ebs differentiated for 3.5 days in a mesoderm inducing condition;	KB_D32off,0.5 microg/ml doxycycline from day 3.0 to day 3.5,,Trizol followed by extraction by 1-butanol and diethyl ether.,
Gene expression data of Flk1 positive cells in Ebs differentiated for 3.5 days in a mesoderm inducing condition. Etv2 was induced to overexpress from day 3.0 to 3.5 (0.5 microg/ml doxycycline).;	KB_D32on,0.5 microg/ml doxycycline from day 3.0 to day 3.5,,Trizol followed by extraction by 1-butanol and diethyl ether.,
Gene expression data of Flk1 positive cells in Ebs differentiated for 3.5 days in a mesoderm inducing condition;	KB_D33off,0.5 microg/ml doxycycline from day 3.0 to day 3.5,,Trizol followed by extraction by 1-butanol and diethyl ether.,
Gene expression data of Flk1 positive cells in Ebs differentiated for 3.5 days in a mesoderm inducing condition. Etv2 was induced to overexpress from day 3.0 to 3.5 (0.5 microg/ml doxycycline).;	KB_D33on,0.5 microg/ml doxycycline from day 3.0 to day 3.5,,Trizol followed by extraction by 1-butanol and diethyl ether.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
total RNA (ribosomal RNA removed);	0_0Gy_0h_A_(HuGene-1_0-st-v1).CEL,Cells were exposed to a challenging dose of 2 Gy of X-rays (160 kVp) 4 hours after receiving a sham exposure (0 Gy) or an adaptive dose of 0.1 Gy.,,Extraction of total RNA was performed according to the manufacturer's instructions. An initial step to remove ribosomal RNA was used to minimize background and to increase detection sensitivity and specificity.  Ribosomal RNA subtraction was conducted using a protocol that was modified by Affymetrix for the RiboMinus Transcriptome Kit (Invitrogen).,
total RNA (ribosomal RNA removed);	0_0Gy_4h_(HuGene-1_0-st-v1).CEL,Cells were exposed to a challenging dose of 2 Gy of X-rays (160 kVp) 4 hours after receiving a sham exposure (0 Gy) or an adaptive dose of 0.1 Gy.,,Extraction of total RNA was performed according to the manufacturer's instructions. An initial step to remove ribosomal RNA was used to minimize background and to increase detection sensitivity and specificity.  Ribosomal RNA subtraction was conducted using a protocol that was modified by Affymetrix for the RiboMinus Transcriptome Kit (Invitrogen).,
total RNA (ribosomal RNA removed);	0.1_2Gy_1h_A_(HuGene-1_0-st-v1).CEL,Cells were exposed to a challenging dose of 2 Gy of X-rays (160 kVp) 4 hours after receiving a sham exposure (0 Gy) or an adaptive dose of 0.1 Gy.,,Extraction of total RNA was performed according to the manufacturer's instructions. An initial step to remove ribosomal RNA was used to minimize background and to increase detection sensitivity and specificity.  Ribosomal RNA subtraction was conducted using a protocol that was modified by Affymetrix for the RiboMinus Transcriptome Kit (Invitrogen).,
total RNA (ribosomal RNA removed);	0.1_2Gy_1h_B_(HuGene-1_0-st-v1).CEL,Cells were exposed to a challenging dose of 2 Gy of X-rays (160 kVp) 4 hours after receiving a sham exposure (0 Gy) or an adaptive dose of 0.1 Gy.,,Extraction of total RNA was performed according to the manufacturer's instructions. An initial step to remove ribosomal RNA was used to minimize background and to increase detection sensitivity and specificity.  Ribosomal RNA subtraction was conducted using a protocol that was modified by Affymetrix for the RiboMinus Transcriptome Kit (Invitrogen).,
total RNA (ribosomal RNA removed);	0.1_2Gy_1h_C_(HuGene-1_0-st-v1).CEL,Cells were exposed to a challenging dose of 2 Gy of X-rays (160 kVp) 4 hours after receiving a sham exposure (0 Gy) or an adaptive dose of 0.1 Gy.,,Extraction of total RNA was performed according to the manufacturer's instructions. An initial step to remove ribosomal RNA was used to minimize background and to increase detection sensitivity and specificity.  Ribosomal RNA subtraction was conducted using a protocol that was modified by Affymetrix for the RiboMinus Transcriptome Kit (Invitrogen).,
total RNA (ribosomal RNA removed);	0.1_2Gy_2h_A_(HuGene-1_0-st-v1).CEL,Cells were exposed to a challenging dose of 2 Gy of X-rays (160 kVp) 4 hours after receiving a sham exposure (0 Gy) or an adaptive dose of 0.1 Gy.,,Extraction of total RNA was performed according to the manufacturer's instructions. An initial step to remove ribosomal RNA was used to minimize background and to increase detection sensitivity and specificity.  Ribosomal RNA subtraction was conducted using a protocol that was modified by Affymetrix for the RiboMinus Transcriptome Kit (Invitrogen).,
total RNA (ribosomal RNA removed);	0.1_2Gy_2h_B_(HuGene-1_0-st-v1).CEL,Cells were exposed to a challenging dose of 2 Gy of X-rays (160 kVp) 4 hours after receiving a sham exposure (0 Gy) or an adaptive dose of 0.1 Gy.,,Extraction of total RNA was performed according to the manufacturer's instructions. An initial step to remove ribosomal RNA was used to minimize background and to increase detection sensitivity and specificity.  Ribosomal RNA subtraction was conducted using a protocol that was modified by Affymetrix for the RiboMinus Transcriptome Kit (Invitrogen).,
total RNA (ribosomal RNA removed);	0.1_2Gy_2h_C_(HuGene-1_0-st-v1).CEL,Cells were exposed to a challenging dose of 2 Gy of X-rays (160 kVp) 4 hours after receiving a sham exposure (0 Gy) or an adaptive dose of 0.1 Gy.,,Extraction of total RNA was performed according to the manufacturer's instructions. An initial step to remove ribosomal RNA was used to minimize background and to increase detection sensitivity and specificity.  Ribosomal RNA subtraction was conducted using a protocol that was modified by Affymetrix for the RiboMinus Transcriptome Kit (Invitrogen).,
total RNA (ribosomal RNA removed);	0.1_2Gy_4h_A_(HuGene-1_0-st-v1).CEL,Cells were exposed to a challenging dose of 2 Gy of X-rays (160 kVp) 4 hours after receiving a sham exposure (0 Gy) or an adaptive dose of 0.1 Gy.,,Extraction of total RNA was performed according to the manufacturer's instructions. An initial step to remove ribosomal RNA was used to minimize background and to increase detection sensitivity and specificity.  Ribosomal RNA subtraction was conducted using a protocol that was modified by Affymetrix for the RiboMinus Transcriptome Kit (Invitrogen).,
total RNA (ribosomal RNA removed);	0.1_2Gy_4h_B_(HuGene-1_0-st-v1).CEL,Cells were exposed to a challenging dose of 2 Gy of X-rays (160 kVp) 4 hours after receiving a sham exposure (0 Gy) or an adaptive dose of 0.1 Gy.,,Extraction of total RNA was performed according to the manufacturer's instructions. An initial step to remove ribosomal RNA was used to minimize background and to increase detection sensitivity and specificity.  Ribosomal RNA subtraction was conducted using a protocol that was modified by Affymetrix for the RiboMinus Transcriptome Kit (Invitrogen).,
total RNA (ribosomal RNA removed);	0.1_2Gy_4h_C_(HuGene-1_0-st-v1).CEL,Cells were exposed to a challenging dose of 2 Gy of X-rays (160 kVp) 4 hours after receiving a sham exposure (0 Gy) or an adaptive dose of 0.1 Gy.,,Extraction of total RNA was performed according to the manufacturer's instructions. An initial step to remove ribosomal RNA was used to minimize background and to increase detection sensitivity and specificity.  Ribosomal RNA subtraction was conducted using a protocol that was modified by Affymetrix for the RiboMinus Transcriptome Kit (Invitrogen).,
total RNA (ribosomal RNA removed);	0.1_2Gy_8h_A_(HuGene-1_0-st-v1).CEL,Cells were exposed to a challenging dose of 2 Gy of X-rays (160 kVp) 4 hours after receiving a sham exposure (0 Gy) or an adaptive dose of 0.1 Gy.,,Extraction of total RNA was performed according to the manufacturer's instructions. An initial step to remove ribosomal RNA was used to minimize background and to increase detection sensitivity and specificity.  Ribosomal RNA subtraction was conducted using a protocol that was modified by Affymetrix for the RiboMinus Transcriptome Kit (Invitrogen).,
total RNA (ribosomal RNA removed);	0.1_2Gy_8h_B_(HuGene-1_0-st-v1).CEL,Cells were exposed to a challenging dose of 2 Gy of X-rays (160 kVp) 4 hours after receiving a sham exposure (0 Gy) or an adaptive dose of 0.1 Gy.,,Extraction of total RNA was performed according to the manufacturer's instructions. An initial step to remove ribosomal RNA was used to minimize background and to increase detection sensitivity and specificity.  Ribosomal RNA subtraction was conducted using a protocol that was modified by Affymetrix for the RiboMinus Transcriptome Kit (Invitrogen).,
total RNA (ribosomal RNA removed);	0.1_2Gy_8h_C_(HuGene-1_0-st-v1).CEL,Cells were exposed to a challenging dose of 2 Gy of X-rays (160 kVp) 4 hours after receiving a sham exposure (0 Gy) or an adaptive dose of 0.1 Gy.,,Extraction of total RNA was performed according to the manufacturer's instructions. An initial step to remove ribosomal RNA was used to minimize background and to increase detection sensitivity and specificity.  Ribosomal RNA subtraction was conducted using a protocol that was modified by Affymetrix for the RiboMinus Transcriptome Kit (Invitrogen).,
total RNA (ribosomal RNA removed);	0_2Gy_1h_A_(HuGene-1_0-st-v1).CEL,Cells were exposed to a challenging dose of 2 Gy of X-rays (160 kVp) 4 hours after receiving a sham exposure (0 Gy) or an adaptive dose of 0.1 Gy.,,Extraction of total RNA was performed according to the manufacturer's instructions. An initial step to remove ribosomal RNA was used to minimize background and to increase detection sensitivity and specificity.  Ribosomal RNA subtraction was conducted using a protocol that was modified by Affymetrix for the RiboMinus Transcriptome Kit (Invitrogen).,
total RNA (ribosomal RNA removed);	0_2Gy_1h_B_(HuGene-1_0-st-v1).CEL,Cells were exposed to a challenging dose of 2 Gy of X-rays (160 kVp) 4 hours after receiving a sham exposure (0 Gy) or an adaptive dose of 0.1 Gy.,,Extraction of total RNA was performed according to the manufacturer's instructions. An initial step to remove ribosomal RNA was used to minimize background and to increase detection sensitivity and specificity.  Ribosomal RNA subtraction was conducted using a protocol that was modified by Affymetrix for the RiboMinus Transcriptome Kit (Invitrogen).,
total RNA (ribosomal RNA removed);	0_2Gy_1h_C_(HuGene-1_0-st-v1).CEL,Cells were exposed to a challenging dose of 2 Gy of X-rays (160 kVp) 4 hours after receiving a sham exposure (0 Gy) or an adaptive dose of 0.1 Gy.,,Extraction of total RNA was performed according to the manufacturer's instructions. An initial step to remove ribosomal RNA was used to minimize background and to increase detection sensitivity and specificity.  Ribosomal RNA subtraction was conducted using a protocol that was modified by Affymetrix for the RiboMinus Transcriptome Kit (Invitrogen).,
total RNA (ribosomal RNA removed);	0_2Gy_2h_A_(HuGene-1_0-st-v1).CEL,Cells were exposed to a challenging dose of 2 Gy of X-rays (160 kVp) 4 hours after receiving a sham exposure (0 Gy) or an adaptive dose of 0.1 Gy.,,Extraction of total RNA was performed according to the manufacturer's instructions. An initial step to remove ribosomal RNA was used to minimize background and to increase detection sensitivity and specificity.  Ribosomal RNA subtraction was conducted using a protocol that was modified by Affymetrix for the RiboMinus Transcriptome Kit (Invitrogen).,
total RNA (ribosomal RNA removed);	0_2Gy_2h_B_(HuGene-1_0-st-v1).CEL,Cells were exposed to a challenging dose of 2 Gy of X-rays (160 kVp) 4 hours after receiving a sham exposure (0 Gy) or an adaptive dose of 0.1 Gy.,,Extraction of total RNA was performed according to the manufacturer's instructions. An initial step to remove ribosomal RNA was used to minimize background and to increase detection sensitivity and specificity.  Ribosomal RNA subtraction was conducted using a protocol that was modified by Affymetrix for the RiboMinus Transcriptome Kit (Invitrogen).,
total RNA (ribosomal RNA removed);	0_2Gy_4h_A_(HuGene-1_0-st-v1).CEL,Cells were exposed to a challenging dose of 2 Gy of X-rays (160 kVp) 4 hours after receiving a sham exposure (0 Gy) or an adaptive dose of 0.1 Gy.,,Extraction of total RNA was performed according to the manufacturer's instructions. An initial step to remove ribosomal RNA was used to minimize background and to increase detection sensitivity and specificity.  Ribosomal RNA subtraction was conducted using a protocol that was modified by Affymetrix for the RiboMinus Transcriptome Kit (Invitrogen).,
total RNA (ribosomal RNA removed);	0_2Gy_4h_B_(HuGene-1_0-st-v1).CEL,Cells were exposed to a challenging dose of 2 Gy of X-rays (160 kVp) 4 hours after receiving a sham exposure (0 Gy) or an adaptive dose of 0.1 Gy.,,Extraction of total RNA was performed according to the manufacturer's instructions. An initial step to remove ribosomal RNA was used to minimize background and to increase detection sensitivity and specificity.  Ribosomal RNA subtraction was conducted using a protocol that was modified by Affymetrix for the RiboMinus Transcriptome Kit (Invitrogen).,
total RNA (ribosomal RNA removed);	0_2Gy_4h_C_(HuGene-1_0-st-v1).CEL,Cells were exposed to a challenging dose of 2 Gy of X-rays (160 kVp) 4 hours after receiving a sham exposure (0 Gy) or an adaptive dose of 0.1 Gy.,,Extraction of total RNA was performed according to the manufacturer's instructions. An initial step to remove ribosomal RNA was used to minimize background and to increase detection sensitivity and specificity.  Ribosomal RNA subtraction was conducted using a protocol that was modified by Affymetrix for the RiboMinus Transcriptome Kit (Invitrogen).,
total RNA (ribosomal RNA removed);	0_2Gy_8h_A_(HuGene-1_0-st-v1).CEL,Cells were exposed to a challenging dose of 2 Gy of X-rays (160 kVp) 4 hours after receiving a sham exposure (0 Gy) or an adaptive dose of 0.1 Gy.,,Extraction of total RNA was performed according to the manufacturer's instructions. An initial step to remove ribosomal RNA was used to minimize background and to increase detection sensitivity and specificity.  Ribosomal RNA subtraction was conducted using a protocol that was modified by Affymetrix for the RiboMinus Transcriptome Kit (Invitrogen).,
total RNA (ribosomal RNA removed);	0_2Gy_8h_B_(HuGene-1_0-st-v1).CEL,Cells were exposed to a challenging dose of 2 Gy of X-rays (160 kVp) 4 hours after receiving a sham exposure (0 Gy) or an adaptive dose of 0.1 Gy.,,Extraction of total RNA was performed according to the manufacturer's instructions. An initial step to remove ribosomal RNA was used to minimize background and to increase detection sensitivity and specificity.  Ribosomal RNA subtraction was conducted using a protocol that was modified by Affymetrix for the RiboMinus Transcriptome Kit (Invitrogen).,
total RNA (ribosomal RNA removed);	0_2Gy_8h_C_(HuGene-1_0-st-v1).CEL,Cells were exposed to a challenging dose of 2 Gy of X-rays (160 kVp) 4 hours after receiving a sham exposure (0 Gy) or an adaptive dose of 0.1 Gy.,,Extraction of total RNA was performed according to the manufacturer's instructions. An initial step to remove ribosomal RNA was used to minimize background and to increase detection sensitivity and specificity.  Ribosomal RNA subtraction was conducted using a protocol that was modified by Affymetrix for the RiboMinus Transcriptome Kit (Invitrogen).,
,No treatment was done with either CD8+ in vitro-derived cells or thymocytes.,No treatment was done with either CD8+ in vitro-derived cells or thymocytes.,Total RNA extracted using Trizol following manufacturer's instructions,Total RNA extracted using Trizol following manufacturer's instructions
,No treatment was done with either CD8+ in vitro-derived cells or thymocytes.,No treatment was done with either CD8+ in vitro-derived cells or thymocytes.,Total RNA extracted using Trizol following manufacturer's instructions,Total RNA extracted using Trizol following manufacturer's instructions
,No treatment was done with either CD8+ in vitro-derived cells or thymocytes.,No treatment was done with either CD8+ in vitro-derived cells or thymocytes.,Total RNA extracted using Trizol following manufacturer's instructions,Total RNA extracted using Trizol following manufacturer's instructions
,No treatment was done with either CD8+ in vitro-derived cells or thymocytes.,No treatment was done with either CD8+ in vitro-derived cells or thymocytes.,Total RNA extracted using Trizol following manufacturer's instructions,Total RNA extracted using Trizol following manufacturer's instructions
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
Antibody in CSF.;	We used a CAMAG Automatic TLC Sampler (ATS4) robot to spray 200nl of 10 to 100 pmol of lipids onto PVDF membranes affixed to the surface of microscope slides.,,,All human CSF samples were collected by lumbar puncture and used under protocols approved by the Institutional Review Boards of the Karolinska Institute and Stanford University.,
n/a,n/a,,"Total RNA was isolated from samples using Plant RNA Reagent (Invitrogen, California, USA), according to the manufacturers instruction. RNA was further purified through a Qiagen RNeasy column (Qiagen, Australia) after pre-treatment with RNase-free DNase I",
n/a,n/a,,"Total RNA was isolated from samples using Plant RNA Reagent (Invitrogen, California, USA), according to the manufacturers instruction. RNA was further purified through a Qiagen RNeasy column (Qiagen, Australia) after pre-treatment with RNase-free DNase I",
Biological replicate 1 of 4. Compression xylem vs. opposite xylem,Compression wood was induced by bending the stem at an angle of 45 away from the vertical during two months.,Compression wood was induced by bending the stem at an angle of 45 away from the vertical during two months.,"Total RNA was isolated following the method of Chang S et al. Plant Mol Biol Rep 1993, 11:113116","Total RNA was isolated following the method of Chang S et al. Plant Mol Biol Rep 1993, 11:113116"
Biological replicate 2 of 4. Compression xylem vs. opposite xylem,Compression wood was induced by bending the stem at an angle of 45 away from the vertical during two months.,Compression wood was induced by bending the stem at an angle of 45 away from the vertical during two months.,"Total RNA was isolated following the method of Chang S et al. Plant Mol Biol Rep 1993, 11:113116","Total RNA was isolated following the method of Chang S et al. Plant Mol Biol Rep 1993, 11:113116"
Biological replicate 3 of 4. Compression xylem vs. opposite xylem,Compression wood was induced by bending the stem at an angle of 45 away from the vertical during two months.,Compression wood was induced by bending the stem at an angle of 45 away from the vertical during two months.,"Total RNA was isolated following the method of Chang S et al. Plant Mol Biol Rep 1993, 11:113116","Total RNA was isolated following the method of Chang S et al. Plant Mol Biol Rep 1993, 11:113116"
Biological replicate 4 of 4. Compression xylem vs. opposite xylem,Compression wood was induced by bending the stem at an angle of 45 away from the vertical during two months.,Compression wood was induced by bending the stem at an angle of 45 away from the vertical during two months.,"Total RNA was isolated following the method of Chang S et al. Plant Mol Biol Rep 1993, 11:113116","Total RNA was isolated following the method of Chang S et al. Plant Mol Biol Rep 1993, 11:113116"
Biological replicate 1 of 4. Dye-Swap. Opposite xylem vs. compression xylem,Compression wood was induced by bending the stem at an angle of 45 away from the vertical during two months.,Compression wood was induced by bending the stem at an angle of 45 away from the vertical during two months.,"Total RNA was isolated following the method of Chang S et al. Plant Mol Biol Rep 1993, 11:113116","Total RNA was isolated following the method of Chang S et al. Plant Mol Biol Rep 1993, 11:113116"
Biological replicate 2 of 4. Dye-Swap. Opposite xylem vs. compression xylem,Compression wood was induced by bending the stem at an angle of 45 away from the vertical during two months.,Compression wood was induced by bending the stem at an angle of 45 away from the vertical during two months.,"Total RNA was isolated following the method of Chang S et al. Plant Mol Biol Rep 1993, 11:113116","Total RNA was isolated following the method of Chang S et al. Plant Mol Biol Rep 1993, 11:113116"
Biological replicate 3 of 4. Dye-Swap. Opposite xylem vs. compression xylem,Compression wood was induced by bending the stem at an angle of 45 away from the vertical during two months.,Compression wood was induced by bending the stem at an angle of 45 away from the vertical during two months.,"Total RNA was isolated following the method of Chang S et al. Plant Mol Biol Rep 1993, 11:113116","Total RNA was isolated following the method of Chang S et al. Plant Mol Biol Rep 1993, 11:113116"
Biological replicate 4 of 4. Dye-Swap. Opposite xylem vs. compression xylem,Compression wood was induced by bending the stem at an angle of 45 away from the vertical during two months.,Compression wood was induced by bending the stem at an angle of 45 away from the vertical during two months.,"Total RNA was isolated following the method of Chang S et al. Plant Mol Biol Rep 1993, 11:113116","Total RNA was isolated following the method of Chang S et al. Plant Mol Biol Rep 1993, 11:113116"
M5311-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F4666-liver-Uninfected,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F4656-liver-Uninfected,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F4656-liver-Uninfected,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5302-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M5311-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F4630-liver-Uninfected,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5302-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M5286-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5302-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M5239-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M5260-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M5239-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M5277-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M4679-liver-Uninfected,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5284-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M4640-liver-Uninfected,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M5239-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M5277-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M4657-liver-Uninfected,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M5235-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M4607-liver-Uninfected,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M5235-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5221-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M5235-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5310-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M4646-liver-Uninfected,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5252-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5282-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F4666-liver-Uninfected,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5221-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F4620-liver-Uninfected,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5252-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5243-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M5250-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M5306-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M4660-liver-Uninfected,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M5276-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5288-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M5276-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M5260-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F4630-liver-Uninfected,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5315-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M5269-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M5276-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5307-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M4679-liver-Uninfected,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5211-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M4660-liver-Uninfected,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5211-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5315-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5211-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M5306-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M5274-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M5250-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5316-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M4607-liver-Uninfected,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5282-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M4646-liver-Uninfected,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5252-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5281-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M5250-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5221-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F4620-liver-Uninfected,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5271-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5243-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5271-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5288-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F4656-liver-Uninfected,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M5260-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M5286-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5271-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M5269-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F4630-liver-Uninfected,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M5301-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M4657-liver-Uninfected,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M5301-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5307-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M5301-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M5277-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5284-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5305-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M5274-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M4640-liver-Uninfected,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5305-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5310-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5305-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5282-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M4646-liver-Uninfected,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5220-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5281-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5220-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5243-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M4660-liver-Uninfected,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5288-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M5306-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5220-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M5286-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M4640-liver-Uninfected,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5227-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M4679-liver-Uninfected,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5227-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M5269-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5227-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5307-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5315-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M5240-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5284-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M4657-liver-Uninfected,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M5274-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M4607-liver-Uninfected,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M5240-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M5311-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
M5240-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5316-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F4666-liver-Uninfected,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5259-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5310-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5259-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5281-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F4620-liver-Uninfected,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5316-liver-Resolved,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5259-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
F5305-liver-Chronic,,,"Total RNA was isolated from liver tissues using the QIAamp RNA Blood Mini Kit (Qiagen Inc., Valencia, CA). 10 g of total RNA isolated were reverse-transcribed using SuperScript double-stranded cDNA synthesis kit (Invitrogen, Inc., Calsbad, CA).",
replicate 1,,,"The RNA was isolated using RNeasy Mini Kit (Quiagen), and DNase digestion  (RNase-free DNase Set, Quiagen) has been applied on the columns during  isolation.",
replicate 2,,,"The RNA was isolated using RNeasy Mini Kit (Quiagen), and DNase digestion  (RNase-free DNase Set, Quiagen) has been applied on the columns during  isolation.",
replicate 1,,,"The RNA was isolated using RNeasy Mini Kit (Quiagen), and DNase digestion  (RNase-free DNase Set, Quiagen) has been applied on the columns during  isolation.",
replicate 2,,,"The RNA was isolated using RNeasy Mini Kit (Quiagen), and DNase digestion  (RNase-free DNase Set, Quiagen) has been applied on the columns during  isolation.",
replicate 1,,,"The RNA was isolated using RNeasy Mini Kit (Quiagen), and DNase digestion  (RNase-free DNase Set, Quiagen) has been applied on the columns during  isolation.",
replicate 2,,,"The RNA was isolated using RNeasy Mini Kit (Quiagen), and DNase digestion  (RNase-free DNase Set, Quiagen) has been applied on the columns during  isolation.",
Control,,,Total RNA was extracted using Trizol reagent. RNAs with a RIN value >9 were used for global microRNA analysis,
Control,,,Total RNA was extracted using Trizol reagent. RNAs with a RIN value >9 were used for global microRNA analysis,
Control,,,Total RNA was extracted using Trizol reagent. RNAs with a RIN value >9 were used for global microRNA analysis,
Test,,,Total RNA was extracted using Trizol reagent. RNAs with a RIN value >9 were used for global microRNA analysis,
Test,,,Total RNA was extracted using Trizol reagent. RNAs with a RIN value >9 were used for global microRNA analysis,
Test,,,Total RNA was extracted using Trizol reagent. RNAs with a RIN value >9 were used for global microRNA analysis,
Control,,,Total RNA was extracted using Trizol reagent. RNAs with a RIN value >9 were used for global microRNA analysis,
Control,,,Total RNA was extracted using Trizol reagent. RNAs with a RIN value >9 were used for global microRNA analysis,
Control,,,Total RNA was extracted using Trizol reagent. RNAs with a RIN value >9 were used for global microRNA analysis,
Test,,,Total RNA was extracted using Trizol reagent. RNAs with a RIN value >9 were used for global microRNA analysis,
Test,,,Total RNA was extracted using Trizol reagent. RNAs with a RIN value >9 were used for global microRNA analysis,
Test,,,Total RNA was extracted using Trizol reagent. RNAs with a RIN value >9 were used for global microRNA analysis,
d21 NT rep 1;	NT_504_29,"IL-13 (50 ng/ml) was added starting day -2 (two days before ALI), and twice weekly for 21 days thereafter.",,Total RNA was isolated from hTECs using the Qiagen RNEasy kit (Qiagen),
d21 NT rep 2;	NT_504_30,"IL-13 (50 ng/ml) was added starting day -2 (two days before ALI), and twice weekly for 21 days thereafter.",,Total RNA was isolated from hTECs using the Qiagen RNEasy kit (Qiagen),
d21 NT rep 3;	NT_504_31,"IL-13 (50 ng/ml) was added starting day -2 (two days before ALI), and twice weekly for 21 days thereafter.",,Total RNA was isolated from hTECs using the Qiagen RNEasy kit (Qiagen),
d21 NT rep 4;	NT_504_32,"IL-13 (50 ng/ml) was added starting day -2 (two days before ALI), and twice weekly for 21 days thereafter.",,Total RNA was isolated from hTECs using the Qiagen RNEasy kit (Qiagen),
d21 IL-13 rep 1;	IL13_504_33,"IL-13 (50 ng/ml) was added starting day -2 (two days before ALI), and twice weekly for 21 days thereafter.",,Total RNA was isolated from hTECs using the Qiagen RNEasy kit (Qiagen),
d21 IL-13 rep 2;	IL13_504_34,"IL-13 (50 ng/ml) was added starting day -2 (two days before ALI), and twice weekly for 21 days thereafter.",,Total RNA was isolated from hTECs using the Qiagen RNEasy kit (Qiagen),
d21 IL-13 rep 3;	IL13_504_35,"IL-13 (50 ng/ml) was added starting day -2 (two days before ALI), and twice weekly for 21 days thereafter.",,Total RNA was isolated from hTECs using the Qiagen RNEasy kit (Qiagen),
d21 IL-13 rep 4;	IL13_504_36,"IL-13 (50 ng/ml) was added starting day -2 (two days before ALI), and twice weekly for 21 days thereafter.",,Total RNA was isolated from hTECs using the Qiagen RNEasy kit (Qiagen),
culture treated with Gld2 shRNA,,,thermally eluted from polyU Sepharose,
culture treated with Gld2 shRNA,,,thermally eluted from polyU Sepharose,
control culture treated with scrambled shRNA,,,thermally eluted from polyU Sepharose,
control culture treated with scrambled shRNA,,,thermally eluted from polyU Sepharose,
Gene expression data from Drosophila S2 cells,Drosophila S2 cells treated with 0.1 mM protocatechuic aldehyde for 2hr.,,Total RNA was isolated using the RNeasy Mini kit.,
Gene expression data from Drosophila S2 cells,Drosophila S2 cells treated with 0.1 mM protocatechuic aldehyde for 2hr.,,Total RNA was isolated using the RNeasy Mini kit.,
Gene expression data from Drosophila S2 cells,Drosophila S2 cells treated with 0.1 mM protocatechuic aldehyde for 2hr.,,Total RNA was isolated using the RNeasy Mini kit.,
Gene expression data from Drosophila S2 cells,Drosophila S2 cells treated with 0.1 mM protocatechuic aldehyde for 2hr.,,Total RNA was isolated using the RNeasy Mini kit.,
Gene expression data from Drosophila S2 cells,Drosophila S2 cells treated with 0.1 mM protocatechuic aldehyde for 2hr.,,Total RNA was isolated using the RNeasy Mini kit.,
Gene expression data from Drosophila S2 cells,Drosophila S2 cells treated with 0.1 mM protocatechuic aldehyde for 2hr.,,Total RNA was isolated using the RNeasy Mini kit.,
Gene expression data from MEFs,No treatment was performed.,,Total RNA was extracted with Trizol reagent according to the manufacturer's protocol.,
Gene expression data from MEFs,No treatment was performed.,,Total RNA was extracted with Trizol reagent according to the manufacturer's protocol.,
Exon expression data from neurons,The mice were not treated before being sacrificed.,,Total RNA was extracted with Trizol reagent according to the manufacturer's protocol.,
Exon expression data from neurons,The mice were not treated before being sacrificed.,,Total RNA was extracted with Trizol reagent according to the manufacturer's protocol.,
Exon expression data from neurons,The mice were not treated before being sacrificed.,,Total RNA was extracted with Trizol reagent according to the manufacturer's protocol.,
Exon expression data from neurons,The mice were not treated before being sacrificed.,,Total RNA was extracted with Trizol reagent according to the manufacturer's protocol.,
"X690_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X691_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X693_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X695_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X696_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X697_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X698_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X702_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X703_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X705_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X706_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X707_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X709_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X713_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X714_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X715_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X716_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X717_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X718_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X720_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X721_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X722_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X723_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X724_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X725_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X728_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X730_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X731_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X733_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X734_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X735_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X736_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X737_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X805_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X806_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X807_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X808_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X810_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X812_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X813_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X933_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X934_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X935_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X936_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X937_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
"X938_E.CEL;	Pool of 8-15 individuals from an inbred line derived from a natural population in Raleigh, North Carolina (kindly provided by the laboratory of Dr. Trudy F. C. Mackay, NC State University)","Prior to injection, the bacterial culture was grown in LB broth + streptomycin (100g/ml) from a single colony of a streptomycin resistant strain of Escherichia coli until OD600 reached 1.0  0.1 (Beckman DU-65 Spectrophotometer, Beckman, Fullerton, CA, USA), corresponding to a final concentration of approximately 5.5x10^8 colony forming units/ml.  The bacterial solution was then loaded into pulled-glass capillary needles.  Bacteria-filled capillary needles were connected to an Eppendorf Femtojet microinjector (Eppendorf, Westbury, NY, USA) and flies were injected with the same volume of E. coli in the abdomen (microinjector settings: injection pressure = 0.46, injection time = 0.2s, and compensation pressure = 0.20) or were sham-injected with sterile Ringer's solution. Bacterially infected and sham-injected flies from each of the lines at each time point were frozen at -80C six hours post-injection",,"Total RNA was extracted using the TRIzol extraction method, followed by an RNeasy cleanup, according to the manufacturers instructions (Invitrogen/Qiagen).",
SAMPLE 5;	replicate 1,,,"The RNA was isolated using RNeasy Mini Kit (Quiagen), and DNase digestion  (RNase-free DNase Set, Quiagen) has been applied on the columns during  isolation.",
SAMPLE 6;	replicate 2,,,"The RNA was isolated using RNeasy Mini Kit (Quiagen), and DNase digestion  (RNase-free DNase Set, Quiagen) has been applied on the columns during  isolation.",
SAMPLE 7;	replicate 1,,,"The RNA was isolated using RNeasy Mini Kit (Quiagen), and DNase digestion  (RNase-free DNase Set, Quiagen) has been applied on the columns during  isolation.",
SAMPLE 8;	replicate 2,,,"The RNA was isolated using RNeasy Mini Kit (Quiagen), and DNase digestion  (RNase-free DNase Set, Quiagen) has been applied on the columns during  isolation.",
SAMPLE 9;	replicate 1,,,"The RNA was isolated using RNeasy Mini Kit (Quiagen), and DNase digestion  (RNase-free DNase Set, Quiagen) has been applied on the columns during  isolation.",
SAMPLE 10;	replicate 2,,,"The RNA was isolated using RNeasy Mini Kit (Quiagen), and DNase digestion  (RNase-free DNase Set, Quiagen) has been applied on the columns during  isolation.",
SAMPLE 11;	replicate 1,,,"The RNA was isolated using RNeasy Mini Kit (Quiagen), and DNase digestion  (RNase-free DNase Set, Quiagen) has been applied on the columns during  isolation.",
SAMPLE 12;	replicate 2,,,"The RNA was isolated using RNeasy Mini Kit (Quiagen), and DNase digestion  (RNase-free DNase Set, Quiagen) has been applied on the columns during  isolation.",
SAMPLE 17;	replicate 1,,,"The RNA was isolated using RNeasy Mini Kit (Quiagen), and DNase digestion  (RNase-free DNase Set, Quiagen) has been applied on the columns during  isolation.",
SAMPLE 18;	replicate 2,,,"The RNA was isolated using RNeasy Mini Kit (Quiagen), and DNase digestion  (RNase-free DNase Set, Quiagen) has been applied on the columns during  isolation.",
SAMPLE 19;	replicate 1,,,"The RNA was isolated using RNeasy Mini Kit (Quiagen), and DNase digestion  (RNase-free DNase Set, Quiagen) has been applied on the columns during  isolation.",
SAMPLE 20;	replicate 2,,,"The RNA was isolated using RNeasy Mini Kit (Quiagen), and DNase digestion  (RNase-free DNase Set, Quiagen) has been applied on the columns during  isolation.",
SAMPLE 21;	replicate 1,,,"The RNA was isolated using RNeasy Mini Kit (Quiagen), and DNase digestion  (RNase-free DNase Set, Quiagen) has been applied on the columns during  isolation.",
SAMPLE 22;	replicate 2,,,"The RNA was isolated using RNeasy Mini Kit (Quiagen), and DNase digestion  (RNase-free DNase Set, Quiagen) has been applied on the columns during  isolation.",
SAMPLE 23;	replicate 1,,,"The RNA was isolated using RNeasy Mini Kit (Quiagen), and DNase digestion  (RNase-free DNase Set, Quiagen) has been applied on the columns during  isolation.",
SAMPLE 24;	replicate 2,,,"The RNA was isolated using RNeasy Mini Kit (Quiagen), and DNase digestion  (RNase-free DNase Set, Quiagen) has been applied on the columns during  isolation.",
SAMPLE 25;	replicate 1,,,"The RNA was isolated using RNeasy Mini Kit (Quiagen), and DNase digestion  (RNase-free DNase Set, Quiagen) has been applied on the columns during  isolation.",
SAMPLE 26;	replicate 1,,,"The RNA was isolated using RNeasy Mini Kit (Quiagen), and DNase digestion  (RNase-free DNase Set, Quiagen) has been applied on the columns during  isolation.",
SAMPLE 27;	replicate 1,,,"The RNA was isolated using RNeasy Mini Kit (Quiagen), and DNase digestion  (RNase-free DNase Set, Quiagen) has been applied on the columns during  isolation.",
SAMPLE 28;	replicate 1,,,"The RNA was isolated using RNeasy Mini Kit (Quiagen), and DNase digestion  (RNase-free DNase Set, Quiagen) has been applied on the columns during  isolation.",
SAMPLE 29;	replicate 1,,,"The RNA was isolated using RNeasy Mini Kit (Quiagen), and DNase digestion  (RNase-free DNase Set, Quiagen) has been applied on the columns during  isolation.",
SAMPLE 30;	replicate 2,,,"The RNA was isolated using RNeasy Mini Kit (Quiagen), and DNase digestion  (RNase-free DNase Set, Quiagen) has been applied on the columns during  isolation.",
SAMPLE 35;	replicate 1,,,"The RNA was isolated using RNeasy Mini Kit (Quiagen), and DNase digestion  (RNase-free DNase Set, Quiagen) has been applied on the columns during  isolation.",
SAMPLE 36;	replicate 2,,,"The RNA was isolated using RNeasy Mini Kit (Quiagen), and DNase digestion  (RNase-free DNase Set, Quiagen) has been applied on the columns during  isolation.",
SAMPLE 37;	replicate 1,,,"The RNA was isolated using RNeasy Mini Kit (Quiagen), and DNase digestion  (RNase-free DNase Set, Quiagen) has been applied on the columns during  isolation.",
SAMPLE 38;	replicate 2,,,"The RNA was isolated using RNeasy Mini Kit (Quiagen), and DNase digestion  (RNase-free DNase Set, Quiagen) has been applied on the columns during  isolation.",
SAMPLE 39;	replicate 1,,,"The RNA was isolated using RNeasy Mini Kit (Quiagen), and DNase digestion  (RNase-free DNase Set, Quiagen) has been applied on the columns during  isolation.",
SAMPLE 40;	replicate 2,,,"The RNA was isolated using RNeasy Mini Kit (Quiagen), and DNase digestion  (RNase-free DNase Set, Quiagen) has been applied on the columns during  isolation.",
SAMPLE 41;	replicate 1,,,"The RNA was isolated using RNeasy Mini Kit (Quiagen), and DNase digestion  (RNase-free DNase Set, Quiagen) has been applied on the columns during  isolation.",
SAMPLE 42;	replicate 1,,,"The RNA was isolated using RNeasy Mini Kit (Quiagen), and DNase digestion  (RNase-free DNase Set, Quiagen) has been applied on the columns during  isolation.",
SAMPLE 43;	replicate 1,,,"The RNA was isolated using RNeasy Mini Kit (Quiagen), and DNase digestion  (RNase-free DNase Set, Quiagen) has been applied on the columns during  isolation.",
SAMPLE 44;	replicate 1,,,"The RNA was isolated using RNeasy Mini Kit (Quiagen), and DNase digestion  (RNase-free DNase Set, Quiagen) has been applied on the columns during  isolation.",
SAMPLE 45;	replicate 1,,,"The RNA was isolated using RNeasy Mini Kit (Quiagen), and DNase digestion  (RNase-free DNase Set, Quiagen) has been applied on the columns during  isolation.",
SAMPLE 46;	replicate 1,,,"The RNA was isolated using RNeasy Mini Kit (Quiagen), and DNase digestion  (RNase-free DNase Set, Quiagen) has been applied on the columns during  isolation.",
SAMPLE 47;	replicate 1,,,"The RNA was isolated using RNeasy Mini Kit (Quiagen), and DNase digestion  (RNase-free DNase Set, Quiagen) has been applied on the columns during  isolation.",
SAMPLE 48;	replicate 1,,,"The RNA was isolated using RNeasy Mini Kit (Quiagen), and DNase digestion  (RNase-free DNase Set, Quiagen) has been applied on the columns during  isolation.",
,,,"RNA extraction was completed using the TRIzol protocol or the MagMax-96 for Microarray kit following the manufacturers instructions. The TURBO DNase treatment or RNeasy kit in conjunction with the RNase-Free DNase Set was used to further purify the initial RNA isolation according to the manufacturers recommendations. The DNA-free RNA isolations with ABS 260/280 ratios above 1.7 and two distinct peaks representing the 18S and 28S ribosomal RNA and minimal background banding, were selected for analysis.",
,,,"RNA extraction was completed using the TRIzol protocol or the MagMax-96 for Microarray kit following the manufacturers instructions. The TURBO DNase treatment or RNeasy kit in conjunction with the RNase-Free DNase Set was used to further purify the initial RNA isolation according to the manufacturers recommendations. The DNA-free RNA isolations with ABS 260/280 ratios above 1.7 and two distinct peaks representing the 18S and 28S ribosomal RNA and minimal background banding, were selected for analysis.",
,,,"RNA extraction was completed using the TRIzol protocol or the MagMax-96 for Microarray kit following the manufacturers instructions. The TURBO DNase treatment or RNeasy kit in conjunction with the RNase-Free DNase Set was used to further purify the initial RNA isolation according to the manufacturers recommendations. The DNA-free RNA isolations with ABS 260/280 ratios above 1.7 and two distinct peaks representing the 18S and 28S ribosomal RNA and minimal background banding, were selected for analysis.",
,,,"RNA extraction was completed using the TRIzol protocol or the MagMax-96 for Microarray kit following the manufacturers instructions. The TURBO DNase treatment or RNeasy kit in conjunction with the RNase-Free DNase Set was used to further purify the initial RNA isolation according to the manufacturers recommendations. The DNA-free RNA isolations with ABS 260/280 ratios above 1.7 and two distinct peaks representing the 18S and 28S ribosomal RNA and minimal background banding, were selected for analysis.",
,,,"RNA extraction was completed using the TRIzol protocol or the MagMax-96 for Microarray kit following the manufacturers instructions. The TURBO DNase treatment or RNeasy kit in conjunction with the RNase-Free DNase Set was used to further purify the initial RNA isolation according to the manufacturers recommendations. The DNA-free RNA isolations with ABS 260/280 ratios above 1.7 and two distinct peaks representing the 18S and 28S ribosomal RNA and minimal background banding, were selected for analysis.",
,,,"RNA extraction was completed using the TRIzol protocol or the MagMax-96 for Microarray kit following the manufacturers instructions. The TURBO DNase treatment or RNeasy kit in conjunction with the RNase-Free DNase Set was used to further purify the initial RNA isolation according to the manufacturers recommendations. The DNA-free RNA isolations with ABS 260/280 ratios above 1.7 and two distinct peaks representing the 18S and 28S ribosomal RNA and minimal background banding, were selected for analysis.",
,,,"RNA extraction was completed using the TRIzol protocol or the MagMax-96 for Microarray kit following the manufacturers instructions. The TURBO DNase treatment or RNeasy kit in conjunction with the RNase-Free DNase Set was used to further purify the initial RNA isolation according to the manufacturers recommendations. The DNA-free RNA isolations with ABS 260/280 ratios above 1.7 and two distinct peaks representing the 18S and 28S ribosomal RNA and minimal background banding, were selected for analysis.",
,,,"RNA extraction was completed using the TRIzol protocol or the MagMax-96 for Microarray kit following the manufacturers instructions. The TURBO DNase treatment or RNeasy kit in conjunction with the RNase-Free DNase Set was used to further purify the initial RNA isolation according to the manufacturers recommendations. The DNA-free RNA isolations with ABS 260/280 ratios above 1.7 and two distinct peaks representing the 18S and 28S ribosomal RNA and minimal background banding, were selected for analysis.",
,,,"RNA extraction was completed using the TRIzol protocol or the MagMax-96 for Microarray kit following the manufacturers instructions. The TURBO DNase treatment or RNeasy kit in conjunction with the RNase-Free DNase Set was used to further purify the initial RNA isolation according to the manufacturers recommendations. The DNA-free RNA isolations with ABS 260/280 ratios above 1.7 and two distinct peaks representing the 18S and 28S ribosomal RNA and minimal background banding, were selected for analysis.",
,,,"RNA extraction was completed using the TRIzol protocol or the MagMax-96 for Microarray kit following the manufacturers instructions. The TURBO DNase treatment or RNeasy kit in conjunction with the RNase-Free DNase Set was used to further purify the initial RNA isolation according to the manufacturers recommendations. The DNA-free RNA isolations with ABS 260/280 ratios above 1.7 and two distinct peaks representing the 18S and 28S ribosomal RNA and minimal background banding, were selected for analysis.",
normalized data is based on two replicates represented as SAMPLE 11 and SAMPLE 38 in the non-normalized.txt raw data file,,,"RNA extraction was completed using the TRIzol protocol or the MagMax-96 for Microarray kit following the manufacturers instructions. The TURBO DNase treatment or RNeasy kit in conjunction with the RNase-Free DNase Set was used to further purify the initial RNA isolation according to the manufacturers recommendations. The DNA-free RNA isolations with ABS 260/280 ratios above 1.7 and two distinct peaks representing the 18S and 28S ribosomal RNA and minimal background banding, were selected for analysis.",
,,,"RNA extraction was completed using the TRIzol protocol or the MagMax-96 for Microarray kit following the manufacturers instructions. The TURBO DNase treatment or RNeasy kit in conjunction with the RNase-Free DNase Set was used to further purify the initial RNA isolation according to the manufacturers recommendations. The DNA-free RNA isolations with ABS 260/280 ratios above 1.7 and two distinct peaks representing the 18S and 28S ribosomal RNA and minimal background banding, were selected for analysis.",
,,,"RNA extraction was completed using the TRIzol protocol or the MagMax-96 for Microarray kit following the manufacturers instructions. The TURBO DNase treatment or RNeasy kit in conjunction with the RNase-Free DNase Set was used to further purify the initial RNA isolation according to the manufacturers recommendations. The DNA-free RNA isolations with ABS 260/280 ratios above 1.7 and two distinct peaks representing the 18S and 28S ribosomal RNA and minimal background banding, were selected for analysis.",
,,,"RNA extraction was completed using the TRIzol protocol or the MagMax-96 for Microarray kit following the manufacturers instructions. The TURBO DNase treatment or RNeasy kit in conjunction with the RNase-Free DNase Set was used to further purify the initial RNA isolation according to the manufacturers recommendations. The DNA-free RNA isolations with ABS 260/280 ratios above 1.7 and two distinct peaks representing the 18S and 28S ribosomal RNA and minimal background banding, were selected for analysis.",
,,,"RNA extraction was completed using the TRIzol protocol or the MagMax-96 for Microarray kit following the manufacturers instructions. The TURBO DNase treatment or RNeasy kit in conjunction with the RNase-Free DNase Set was used to further purify the initial RNA isolation according to the manufacturers recommendations. The DNA-free RNA isolations with ABS 260/280 ratios above 1.7 and two distinct peaks representing the 18S and 28S ribosomal RNA and minimal background banding, were selected for analysis.",
,,,"RNA extraction was completed using the TRIzol protocol or the MagMax-96 for Microarray kit following the manufacturers instructions. The TURBO DNase treatment or RNeasy kit in conjunction with the RNase-Free DNase Set was used to further purify the initial RNA isolation according to the manufacturers recommendations. The DNA-free RNA isolations with ABS 260/280 ratios above 1.7 and two distinct peaks representing the 18S and 28S ribosomal RNA and minimal background banding, were selected for analysis.",
,,,"RNA extraction was completed using the TRIzol protocol or the MagMax-96 for Microarray kit following the manufacturers instructions. The TURBO DNase treatment or RNeasy kit in conjunction with the RNase-Free DNase Set was used to further purify the initial RNA isolation according to the manufacturers recommendations. The DNA-free RNA isolations with ABS 260/280 ratios above 1.7 and two distinct peaks representing the 18S and 28S ribosomal RNA and minimal background banding, were selected for analysis.",
,,,"RNA extraction was completed using the TRIzol protocol or the MagMax-96 for Microarray kit following the manufacturers instructions. The TURBO DNase treatment or RNeasy kit in conjunction with the RNase-Free DNase Set was used to further purify the initial RNA isolation according to the manufacturers recommendations. The DNA-free RNA isolations with ABS 260/280 ratios above 1.7 and two distinct peaks representing the 18S and 28S ribosomal RNA and minimal background banding, were selected for analysis.",
,,,"RNA extraction was completed using the TRIzol protocol or the MagMax-96 for Microarray kit following the manufacturers instructions. The TURBO DNase treatment or RNeasy kit in conjunction with the RNase-Free DNase Set was used to further purify the initial RNA isolation according to the manufacturers recommendations. The DNA-free RNA isolations with ABS 260/280 ratios above 1.7 and two distinct peaks representing the 18S and 28S ribosomal RNA and minimal background banding, were selected for analysis.",
,,,"RNA extraction was completed using the TRIzol protocol or the MagMax-96 for Microarray kit following the manufacturers instructions. The TURBO DNase treatment or RNeasy kit in conjunction with the RNase-Free DNase Set was used to further purify the initial RNA isolation according to the manufacturers recommendations. The DNA-free RNA isolations with ABS 260/280 ratios above 1.7 and two distinct peaks representing the 18S and 28S ribosomal RNA and minimal background banding, were selected for analysis.",
,,,"RNA extraction was completed using the TRIzol protocol or the MagMax-96 for Microarray kit following the manufacturers instructions. The TURBO DNase treatment or RNeasy kit in conjunction with the RNase-Free DNase Set was used to further purify the initial RNA isolation according to the manufacturers recommendations. The DNA-free RNA isolations with ABS 260/280 ratios above 1.7 and two distinct peaks representing the 18S and 28S ribosomal RNA and minimal background banding, were selected for analysis.",
,,,"RNA extraction was completed using the TRIzol protocol or the MagMax-96 for Microarray kit following the manufacturers instructions. The TURBO DNase treatment or RNeasy kit in conjunction with the RNase-Free DNase Set was used to further purify the initial RNA isolation according to the manufacturers recommendations. The DNA-free RNA isolations with ABS 260/280 ratios above 1.7 and two distinct peaks representing the 18S and 28S ribosomal RNA and minimal background banding, were selected for analysis.",
,,,"RNA extraction was completed using the TRIzol protocol or the MagMax-96 for Microarray kit following the manufacturers instructions. The TURBO DNase treatment or RNeasy kit in conjunction with the RNase-Free DNase Set was used to further purify the initial RNA isolation according to the manufacturers recommendations. The DNA-free RNA isolations with ABS 260/280 ratios above 1.7 and two distinct peaks representing the 18S and 28S ribosomal RNA and minimal background banding, were selected for analysis.",
normalized data is based on two replicates represented as SAMPLE 24 and SAMPLE 39 in the non-normalized.txt raw data file,,,"RNA extraction was completed using the TRIzol protocol or the MagMax-96 for Microarray kit following the manufacturers instructions. The TURBO DNase treatment or RNeasy kit in conjunction with the RNase-Free DNase Set was used to further purify the initial RNA isolation according to the manufacturers recommendations. The DNA-free RNA isolations with ABS 260/280 ratios above 1.7 and two distinct peaks representing the 18S and 28S ribosomal RNA and minimal background banding, were selected for analysis.",
,,,"RNA extraction was completed using the TRIzol protocol or the MagMax-96 for Microarray kit following the manufacturers instructions. The TURBO DNase treatment or RNeasy kit in conjunction with the RNase-Free DNase Set was used to further purify the initial RNA isolation according to the manufacturers recommendations. The DNA-free RNA isolations with ABS 260/280 ratios above 1.7 and two distinct peaks representing the 18S and 28S ribosomal RNA and minimal background banding, were selected for analysis.",
,,,"RNA extraction was completed using the TRIzol protocol or the MagMax-96 for Microarray kit following the manufacturers instructions. The TURBO DNase treatment or RNeasy kit in conjunction with the RNase-Free DNase Set was used to further purify the initial RNA isolation according to the manufacturers recommendations. The DNA-free RNA isolations with ABS 260/280 ratios above 1.7 and two distinct peaks representing the 18S and 28S ribosomal RNA and minimal background banding, were selected for analysis.",
,,,"RNA extraction was completed using the TRIzol protocol or the MagMax-96 for Microarray kit following the manufacturers instructions. The TURBO DNase treatment or RNeasy kit in conjunction with the RNase-Free DNase Set was used to further purify the initial RNA isolation according to the manufacturers recommendations. The DNA-free RNA isolations with ABS 260/280 ratios above 1.7 and two distinct peaks representing the 18S and 28S ribosomal RNA and minimal background banding, were selected for analysis.",
,,,"RNA extraction was completed using the TRIzol protocol or the MagMax-96 for Microarray kit following the manufacturers instructions. The TURBO DNase treatment or RNeasy kit in conjunction with the RNase-Free DNase Set was used to further purify the initial RNA isolation according to the manufacturers recommendations. The DNA-free RNA isolations with ABS 260/280 ratios above 1.7 and two distinct peaks representing the 18S and 28S ribosomal RNA and minimal background banding, were selected for analysis.",
,,,"RNA extraction was completed using the TRIzol protocol or the MagMax-96 for Microarray kit following the manufacturers instructions. The TURBO DNase treatment or RNeasy kit in conjunction with the RNase-Free DNase Set was used to further purify the initial RNA isolation according to the manufacturers recommendations. The DNA-free RNA isolations with ABS 260/280 ratios above 1.7 and two distinct peaks representing the 18S and 28S ribosomal RNA and minimal background banding, were selected for analysis.",
normalized data is based on two replicates represented as SAMPLE 30 and SAMPLE 40 in the non-normalized.txt raw data file,,,"RNA extraction was completed using the TRIzol protocol or the MagMax-96 for Microarray kit following the manufacturers instructions. The TURBO DNase treatment or RNeasy kit in conjunction with the RNase-Free DNase Set was used to further purify the initial RNA isolation according to the manufacturers recommendations. The DNA-free RNA isolations with ABS 260/280 ratios above 1.7 and two distinct peaks representing the 18S and 28S ribosomal RNA and minimal background banding, were selected for analysis.",
,,,"RNA extraction was completed using the TRIzol protocol or the MagMax-96 for Microarray kit following the manufacturers instructions. The TURBO DNase treatment or RNeasy kit in conjunction with the RNase-Free DNase Set was used to further purify the initial RNA isolation according to the manufacturers recommendations. The DNA-free RNA isolations with ABS 260/280 ratios above 1.7 and two distinct peaks representing the 18S and 28S ribosomal RNA and minimal background banding, were selected for analysis.",
,,,"RNA extraction was completed using the TRIzol protocol or the MagMax-96 for Microarray kit following the manufacturers instructions. The TURBO DNase treatment or RNeasy kit in conjunction with the RNase-Free DNase Set was used to further purify the initial RNA isolation according to the manufacturers recommendations. The DNA-free RNA isolations with ABS 260/280 ratios above 1.7 and two distinct peaks representing the 18S and 28S ribosomal RNA and minimal background banding, were selected for analysis.",
,,,"RNA extraction was completed using the TRIzol protocol or the MagMax-96 for Microarray kit following the manufacturers instructions. The TURBO DNase treatment or RNeasy kit in conjunction with the RNase-Free DNase Set was used to further purify the initial RNA isolation according to the manufacturers recommendations. The DNA-free RNA isolations with ABS 260/280 ratios above 1.7 and two distinct peaks representing the 18S and 28S ribosomal RNA and minimal background banding, were selected for analysis.",
,,,"RNA extraction was completed using the TRIzol protocol or the MagMax-96 for Microarray kit following the manufacturers instructions. The TURBO DNase treatment or RNeasy kit in conjunction with the RNase-Free DNase Set was used to further purify the initial RNA isolation according to the manufacturers recommendations. The DNA-free RNA isolations with ABS 260/280 ratios above 1.7 and two distinct peaks representing the 18S and 28S ribosomal RNA and minimal background banding, were selected for analysis.",
,,,"RNA extraction was completed using the TRIzol protocol or the MagMax-96 for Microarray kit following the manufacturers instructions. The TURBO DNase treatment or RNeasy kit in conjunction with the RNase-Free DNase Set was used to further purify the initial RNA isolation according to the manufacturers recommendations. The DNA-free RNA isolations with ABS 260/280 ratios above 1.7 and two distinct peaks representing the 18S and 28S ribosomal RNA and minimal background banding, were selected for analysis.",
,,,"RNA extraction was completed using the TRIzol protocol or the MagMax-96 for Microarray kit following the manufacturers instructions. The TURBO DNase treatment or RNeasy kit in conjunction with the RNase-Free DNase Set was used to further purify the initial RNA isolation according to the manufacturers recommendations. The DNA-free RNA isolations with ABS 260/280 ratios above 1.7 and two distinct peaks representing the 18S and 28S ribosomal RNA and minimal background banding, were selected for analysis.",
,,,"RNA extraction was completed using the TRIzol protocol or the MagMax-96 for Microarray kit following the manufacturers instructions. The TURBO DNase treatment or RNeasy kit in conjunction with the RNase-Free DNase Set was used to further purify the initial RNA isolation according to the manufacturers recommendations. The DNA-free RNA isolations with ABS 260/280 ratios above 1.7 and two distinct peaks representing the 18S and 28S ribosomal RNA and minimal background banding, were selected for analysis.",
,Cells were differentiated in culture along the hematopoietic lineage.  Cells from distinct differentiation stages were collected and RNA prepared.,,Trizol was used for RNA isolation,
,Cells were differentiated in culture along the hematopoietic lineage.  Cells from distinct differentiation stages were collected and RNA prepared.,,Trizol was used for RNA isolation,
,Cells were differentiated in culture along the hematopoietic lineage.  Cells from distinct differentiation stages were collected and RNA prepared.,,Trizol was used for RNA isolation,
,Cells were differentiated in culture along the hematopoietic lineage.  Cells from distinct differentiation stages were collected and RNA prepared.,,Trizol was used for RNA isolation,
,Cells were differentiated in culture along the hematopoietic lineage.  Cells from distinct differentiation stages were collected and RNA prepared.,,Trizol was used for RNA isolation,
,Cells were differentiated in culture along the hematopoietic lineage.  Cells from distinct differentiation stages were collected and RNA prepared.,,Trizol was used for RNA isolation,
"L1;	Biological replicate 1 of 2. Larvae, harvested after 4 days post infestation.",,,Total RNA was isolated according to manufacturers guidelines for TRI REAGENT.,Total RNA was isolated according to manufacturers guidelines for TRI REAGENT.
"L1R;	Technical replicate of biological replicate 1. Larvae, harvested after 4 days post infestation.",,,Total RNA was isolated according to manufacturers guidelines for TRI REAGENT.,Total RNA was isolated according to manufacturers guidelines for TRI REAGENT.
"L2;	Biological replicate 2 of 2. Larvae, harvested after 4 days post infestation.",,,Total RNA was isolated according to manufacturers guidelines for TRI REAGENT.,Total RNA was isolated according to manufacturers guidelines for TRI REAGENT.
"L2R;	Technical replicate of biological replicate 2. Larvae, harvested after 4 days post infestation.",,,Total RNA was isolated according to manufacturers guidelines for TRI REAGENT.,Total RNA was isolated according to manufacturers guidelines for TRI REAGENT.
"N1;	Biological replicate 1 of 2. Nymph, harvested after 7 days post infestation.",,,Total RNA was isolated according to manufacturers guidelines for TRI REAGENT.,Total RNA was isolated according to manufacturers guidelines for TRI REAGENT.
"N1R;	Technical replicate of biological replicate 1. Nymph, harvested after 7 days post infestation.",,,Total RNA was isolated according to manufacturers guidelines for TRI REAGENT.,Total RNA was isolated according to manufacturers guidelines for TRI REAGENT.
"N2;	Biological replicate 2 of 2. Nymph, harvested after 7 days post infestation.",,,Total RNA was isolated according to manufacturers guidelines for TRI REAGENT.,Total RNA was isolated according to manufacturers guidelines for TRI REAGENT.
"N2R;	Technical replicate of biological replicate 2. Nymph, harvested after 7 days post infestation.",,,Total RNA was isolated according to manufacturers guidelines for TRI REAGENT.,Total RNA was isolated according to manufacturers guidelines for TRI REAGENT.
Gene expression in 3day fifth instar larvae in op mutant,Silkworms were reared on fresh mulberry leaves and kept at 25 degrees Celsius on a 12-hour light/12-hour dark cycle.,,"Total RNA from wild type or op testis were isolated using an RNeasy Mini Kit (Qiagen, Valencia, CA, USA). Total RNA was quantified on an Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA, USA)",
Gene expression in 3day fifth instar larvae in op mutant,Silkworms were reared on fresh mulberry leaves and kept at 25 degrees Celsius on a 12-hour light/12-hour dark cycle.,,"Total RNA from wild type or op testis were isolated using an RNeasy Mini Kit (Qiagen, Valencia, CA, USA). Total RNA was quantified on an Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA, USA)",
Gene expression in 3day fifth instar larvae in wild type,Silkworms were reared on fresh mulberry leaves and kept at 25 degrees Celsius on a 12-hour light/12-hour dark cycle.,,"Total RNA from wild type or op testis were isolated using an RNeasy Mini Kit (Qiagen, Valencia, CA, USA). Total RNA was quantified on an Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA, USA)",
Gene expression in 3day fifth instar larvae in wild type,Silkworms were reared on fresh mulberry leaves and kept at 25 degrees Celsius on a 12-hour light/12-hour dark cycle.,,"Total RNA from wild type or op testis were isolated using an RNeasy Mini Kit (Qiagen, Valencia, CA, USA). Total RNA was quantified on an Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA, USA)",
Biological replicate 1 of 4. Compression xylem vs. opposite xylem,Compression wood was induced by bending the stem at an angle of 45 away from the vertical during two months.,Compression wood was induced by bending the stem at an angle of 45 away from the vertical during two months.,"Total RNA was isolated following the method of Chang S et al. Plant Mol Biol Rep 1993, 11:113116","Total RNA was isolated following the method of Chang S et al. Plant Mol Biol Rep 1993, 11:113116"
Biological replicate 2 of 4. Compression xylem vs. opposite xylem,Compression wood was induced by bending the stem at an angle of 45 away from the vertical during two months.,Compression wood was induced by bending the stem at an angle of 45 away from the vertical during two months.,"Total RNA was isolated following the method of Chang S et al. Plant Mol Biol Rep 1993, 11:113116","Total RNA was isolated following the method of Chang S et al. Plant Mol Biol Rep 1993, 11:113116"
Biological replicate 3 of 4. Compression xylem vs. opposite xylem,Compression wood was induced by bending the stem at an angle of 45 away from the vertical during two months.,Compression wood was induced by bending the stem at an angle of 45 away from the vertical during two months.,"Total RNA was isolated following the method of Chang S et al. Plant Mol Biol Rep 1993, 11:113116","Total RNA was isolated following the method of Chang S et al. Plant Mol Biol Rep 1993, 11:113116"
Biological replicate 4 of 4. Compression xylem vs. opposite xylem,Compression wood was induced by bending the stem at an angle of 45 away from the vertical during two months.,Compression wood was induced by bending the stem at an angle of 45 away from the vertical during two months.,"Total RNA was isolated following the method of Chang S et al. Plant Mol Biol Rep 1993, 11:113116","Total RNA was isolated following the method of Chang S et al. Plant Mol Biol Rep 1993, 11:113116"
Biological replicate 1 of 4. Dye-Swap. Opposite xylem vs. compression xylem,Compression wood was induced by bending the stem at an angle of 45 away from the vertical during two months.,Compression wood was induced by bending the stem at an angle of 45 away from the vertical during two months.,"Total RNA was isolated following the method of Chang S et al. Plant Mol Biol Rep 1993, 11:113116","Total RNA was isolated following the method of Chang S et al. Plant Mol Biol Rep 1993, 11:113116"
Biological replicate 2 of 4. Dye-Swap. Opposite xylem vs. compression xylem,Compression wood was induced by bending the stem at an angle of 45 away from the vertical during two months.,Compression wood was induced by bending the stem at an angle of 45 away from the vertical during two months.,"Total RNA was isolated following the method of Chang S et al. Plant Mol Biol Rep 1993, 11:113116","Total RNA was isolated following the method of Chang S et al. Plant Mol Biol Rep 1993, 11:113116"
Biological replicate 3 of 4. Dye-Swap. Opposite xylem vs. compression xylem,Compression wood was induced by bending the stem at an angle of 45 away from the vertical during two months.,Compression wood was induced by bending the stem at an angle of 45 away from the vertical during two months.,"Total RNA was isolated following the method of Chang S et al. Plant Mol Biol Rep 1993, 11:113116","Total RNA was isolated following the method of Chang S et al. Plant Mol Biol Rep 1993, 11:113116"
Biological replicate 4 of 4. Dye-Swap. Opposite xylem vs. compression xylem,Compression wood was induced by bending the stem at an angle of 45 away from the vertical during two months.,Compression wood was induced by bending the stem at an angle of 45 away from the vertical during two months.,"Total RNA was isolated following the method of Chang S et al. Plant Mol Biol Rep 1993, 11:113116","Total RNA was isolated following the method of Chang S et al. Plant Mol Biol Rep 1993, 11:113116"
test,"From each patient, matched tissue parts from the peripheral and the central tumor area were snap frozen immediately after operation and stored at -80C. Tissue specimens were histologically confirmed to represent either the tumor infiltration zone (INF) or cell-rich central tumor areas (CEN) and then subjected to subsequent microdissection.",,Total RNA was extracted by calcium chloride ultracentrifugation.,
test,"From each patient, matched tissue parts from the peripheral and the central tumor area were snap frozen immediately after operation and stored at -80C. Tissue specimens were histologically confirmed to represent either the tumor infiltration zone (INF) or cell-rich central tumor areas (CEN) and then subjected to subsequent microdissection.",,Total RNA was extracted by calcium chloride ultracentrifugation.,
test,"From each patient, matched tissue parts from the peripheral and the central tumor area were snap frozen immediately after operation and stored at -80C. Tissue specimens were histologically confirmed to represent either the tumor infiltration zone (INF) or cell-rich central tumor areas (CEN) and then subjected to subsequent microdissection.",,Total RNA was extracted by calcium chloride ultracentrifugation.,
test,"From each patient, matched tissue parts from the peripheral and the central tumor area were snap frozen immediately after operation and stored at -80C. Tissue specimens were histologically confirmed to represent either the tumor infiltration zone (INF) or cell-rich central tumor areas (CEN) and then subjected to subsequent microdissection.",,Total RNA was extracted by calcium chloride ultracentrifugation.,
test,"From each patient, matched tissue parts from the peripheral and the central tumor area were snap frozen immediately after operation and stored at -80C. Tissue specimens were histologically confirmed to represent either the tumor infiltration zone (INF) or cell-rich central tumor areas (CEN) and then subjected to subsequent microdissection.",,Total RNA was extracted by calcium chloride ultracentrifugation.,
test,"From each patient, matched tissue parts from the peripheral and the central tumor area were snap frozen immediately after operation and stored at -80C. Tissue specimens were histologically confirmed to represent either the tumor infiltration zone (INF) or cell-rich central tumor areas (CEN) and then subjected to subsequent microdissection.",,Total RNA was extracted by calcium chloride ultracentrifugation.,
test,"From each patient, matched tissue parts from the peripheral and the central tumor area were snap frozen immediately after operation and stored at -80C. Tissue specimens were histologically confirmed to represent either the tumor infiltration zone (INF) or cell-rich central tumor areas (CEN) and then subjected to subsequent microdissection.",,Total RNA was extracted by calcium chloride ultracentrifugation.,
control,"From each patient, matched tissue parts from the peripheral and the central tumor area were snap frozen immediately after operation and stored at -80C. Tissue specimens were histologically confirmed to represent either the tumor infiltration zone (INF) or cell-rich central tumor areas (CEN) and then subjected to subsequent microdissection.",,Total RNA was extracted by calcium chloride ultracentrifugation.,
control,"From each patient, matched tissue parts from the peripheral and the central tumor area were snap frozen immediately after operation and stored at -80C. Tissue specimens were histologically confirmed to represent either the tumor infiltration zone (INF) or cell-rich central tumor areas (CEN) and then subjected to subsequent microdissection.",,Total RNA was extracted by calcium chloride ultracentrifugation.,
control,"From each patient, matched tissue parts from the peripheral and the central tumor area were snap frozen immediately after operation and stored at -80C. Tissue specimens were histologically confirmed to represent either the tumor infiltration zone (INF) or cell-rich central tumor areas (CEN) and then subjected to subsequent microdissection.",,Total RNA was extracted by calcium chloride ultracentrifugation.,
control,"From each patient, matched tissue parts from the peripheral and the central tumor area were snap frozen immediately after operation and stored at -80C. Tissue specimens were histologically confirmed to represent either the tumor infiltration zone (INF) or cell-rich central tumor areas (CEN) and then subjected to subsequent microdissection.",,Total RNA was extracted by calcium chloride ultracentrifugation.,
control,"From each patient, matched tissue parts from the peripheral and the central tumor area were snap frozen immediately after operation and stored at -80C. Tissue specimens were histologically confirmed to represent either the tumor infiltration zone (INF) or cell-rich central tumor areas (CEN) and then subjected to subsequent microdissection.",,Total RNA was extracted by calcium chloride ultracentrifugation.,
control,"From each patient, matched tissue parts from the peripheral and the central tumor area were snap frozen immediately after operation and stored at -80C. Tissue specimens were histologically confirmed to represent either the tumor infiltration zone (INF) or cell-rich central tumor areas (CEN) and then subjected to subsequent microdissection.",,Total RNA was extracted by calcium chloride ultracentrifugation.,
control,"From each patient, matched tissue parts from the peripheral and the central tumor area were snap frozen immediately after operation and stored at -80C. Tissue specimens were histologically confirmed to represent either the tumor infiltration zone (INF) or cell-rich central tumor areas (CEN) and then subjected to subsequent microdissection.",,Total RNA was extracted by calcium chloride ultracentrifugation.,
Tag-Seq,,,"At least 400ng of Dnase I-treated total RNA was used for library construction. As per published protocols, cDNA that was synthesized using oligo(dT) beads was digested with NlaIII and then ligated to an Illumina specific adapter containing the MmeI recognition sequence. Following digestion, a second Illumina adapter was added that contained a 2bp degenerate 3' overhang. The adapters were used to amplify by PCR and the products were run on a 12% PAGE gel.",
Tag-Seq,,,"At least 400ng of Dnase I-treated total RNA was used for library construction. As per published protocols, cDNA that was synthesized using oligo(dT) beads was digested with NlaIII and then ligated to an Illumina specific adapter containing the MmeI recognition sequence. Following digestion, a second Illumina adapter was added that contained a 2bp degenerate 3' overhang. The adapters were used to amplify by PCR and the products were run on a 12% PAGE gel.",
Tag-Seq,,,"At least 400ng of Dnase I-treated total RNA was used for library construction. As per published protocols, cDNA that was synthesized using oligo(dT) beads was digested with NlaIII and then ligated to an Illumina specific adapter containing the MmeI recognition sequence. Following digestion, a second Illumina adapter was added that contained a 2bp degenerate 3' overhang. The adapters were used to amplify by PCR and the products were run on a 12% PAGE gel.",
Tag-Seq,,,"At least 400ng of Dnase I-treated total RNA was used for library construction. As per published protocols, cDNA that was synthesized using oligo(dT) beads was digested with NlaIII and then ligated to an Illumina specific adapter containing the MmeI recognition sequence. Following digestion, a second Illumina adapter was added that contained a 2bp degenerate 3' overhang. The adapters were used to amplify by PCR and the products were run on a 12% PAGE gel.",
Tag-Seq,,,"At least 400ng of Dnase I-treated total RNA was used for library construction. As per published protocols, cDNA that was synthesized using oligo(dT) beads was digested with NlaIII and then ligated to an Illumina specific adapter containing the MmeI recognition sequence. Following digestion, a second Illumina adapter was added that contained a 2bp degenerate 3' overhang. The adapters were used to amplify by PCR and the products were run on a 12% PAGE gel.",
1 uM PFUdA replicate 1,,,"Total RNA was isolated from CEH using RNeasy 96 kits (Qiagen), including the on-column DNase treatment according to the manufacturers instructions","Total RNA was isolated from CEH using RNeasy 96 kits (Qiagen), including the on-column DNase treatment according to the manufacturers instructions"
1 uM PFUdA replicate 2,,,"Total RNA was isolated from CEH using RNeasy 96 kits (Qiagen), including the on-column DNase treatment according to the manufacturers instructions","Total RNA was isolated from CEH using RNeasy 96 kits (Qiagen), including the on-column DNase treatment according to the manufacturers instructions"
1 uM PFUdA replicate 3,,,"Total RNA was isolated from CEH using RNeasy 96 kits (Qiagen), including the on-column DNase treatment according to the manufacturers instructions","Total RNA was isolated from CEH using RNeasy 96 kits (Qiagen), including the on-column DNase treatment according to the manufacturers instructions"
1 uM PFUdA replicate 4,,,"Total RNA was isolated from CEH using RNeasy 96 kits (Qiagen), including the on-column DNase treatment according to the manufacturers instructions","Total RNA was isolated from CEH using RNeasy 96 kits (Qiagen), including the on-column DNase treatment according to the manufacturers instructions"
10 uM PFUdA replicate 1,,,"Total RNA was isolated from CEH using RNeasy 96 kits (Qiagen), including the on-column DNase treatment according to the manufacturers instructions","Total RNA was isolated from CEH using RNeasy 96 kits (Qiagen), including the on-column DNase treatment according to the manufacturers instructions"
10 uM PFUdA replicate 2,,,"Total RNA was isolated from CEH using RNeasy 96 kits (Qiagen), including the on-column DNase treatment according to the manufacturers instructions","Total RNA was isolated from CEH using RNeasy 96 kits (Qiagen), including the on-column DNase treatment according to the manufacturers instructions"
10 uM PFUdA replicate 3,,,"Total RNA was isolated from CEH using RNeasy 96 kits (Qiagen), including the on-column DNase treatment according to the manufacturers instructions","Total RNA was isolated from CEH using RNeasy 96 kits (Qiagen), including the on-column DNase treatment according to the manufacturers instructions"
10 uM PFUdA replicate 4,,,"Total RNA was isolated from CEH using RNeasy 96 kits (Qiagen), including the on-column DNase treatment according to the manufacturers instructions","Total RNA was isolated from CEH using RNeasy 96 kits (Qiagen), including the on-column DNase treatment according to the manufacturers instructions"
10 uM PFUdA replicate 5,,,"Total RNA was isolated from CEH using RNeasy 96 kits (Qiagen), including the on-column DNase treatment according to the manufacturers instructions","Total RNA was isolated from CEH using RNeasy 96 kits (Qiagen), including the on-column DNase treatment according to the manufacturers instructions"
10864,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
13707,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
3265,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
3630,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
4662,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
5838,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
6065,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
6075,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
6334,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
6500,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
7548,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
7747,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
8114,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
8179,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
8331,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
8405,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
8479,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
8548,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
9512,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
9519,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
9790,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
10248,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
10668,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
10740,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
10744,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
11246,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
11291,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
11472,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
11541,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
12285,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
12379,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
12434,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
12644,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
13163,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
16879,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
19885,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
20017,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
20645,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
21062,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
21090,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
21273,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
21276,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
21318,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
21881,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
21965,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
22529,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
26470,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
3264,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
3631,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
3661,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
4333,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
4663,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
6066,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
6076,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
6335,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
6501,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
7549,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
7748,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
8010,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
8126,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
8180,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
8254,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
8332,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
8406,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
8480,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
8549,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
9513,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
9520,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
9525,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
9769,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
9791,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
10249,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
10669,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
10693,,,"Total RNA was isolated using TRIZOL reagent (Invitrogen, Carlsbad, CA) as directed by the manufacturer. The quantity and quality of RNA was assessed with a Nanodrop 1000 spectrophotometer (Thermo Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).",
